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 The rat has been an established experimental animal model within many areas 
of biological investigation for over one hundred years due to its size, breeding 
characteristics, and knowledge of its physiology and behaviour. In recent years its 
status as a leading biomedical model has been somewhat surpassed by the mouse. 
This is largely the result of the isolation and application of mouse embryonic stem 
(ES) cells. Mouse ES cells have the capacity for unlimited self-renew in vitro whilst 
maintaining pluripotency and germline competence, and most importantly are 
amenable to sophisticated reverse genetics strategies such as gene targeting, which 
have provided a route to germ line modification. Thus far, the derivation of rat ES 
cells has proved elusive. The generation of rat ES cells would therefore facilitate 
equivalent applications to rat genetics and significantly strengthen the rat as an 
experimental model system. 
 Previous attempts to derive rat ES cells led to the isolation of rat ES-like 
cells. However, whilst these cells exhibit extensive self-renew in vitro, it was known 
that they fail to maintain significant levels of the key functional ES cell marker Oct4 
and do not contribute to chimeras. Rather, these cells express the trophectoderm 
markers Cdx2 and CyclinD3, and have been termed ExS cells due to their probable 
extra-embryonic nature. In the work described in this thesis, further investigation of 
ExS cells revealed the absence of expression of the key pluripotency gene Nanog, 
although the expression pattern of Nanog in the rat embryo was shown to be similar 
to that of mouse.  
It was hypothesised that expression of exogenous Oct4 and Nanog or Sox2 
genes could facilitate reprogramming of ExS cells into a 'true' ES cell state. Initial 
 iv
work described in this thesis demonstrated that it was possible to introduce 
transgenes into rat ExS cells and obtain stable transformants with long term 
transgene expression. On this basis Oct 4, Nanog and Sox2 transgene expression 
vectors were constructed and stably integrated into ExS cells, and transgene 
expression verified. However, no reactivation of an endogenous gene expression 
profile, characteristic of a true ES cell-like state, was observed in any of the 
transgenic lines produced.  
Concurrent with work on ExS cells, investigations by others using chemically 
defined, serum-free medium containing small molecule inhibitors of MEK and GSK3 
(called 3i/2i medium) had demonstrated that it was possible to readily isolate mouse 
ES cells, even from strains known to be refractory to ES cell isolation. Therefore, the 
ability of this culture system to facilitate rat ES cell derivation was investigated. Rat 
3i/2i cell lines were established from ICM outgrowths of Fischer, DA and Sprague 
Dawley E4.5 rat embryos. These cells maintained expression of Oct4 and Nanog and 
could generate complex teratomas consisting of all three germ layers. They were 
distinct from epiblast stem cells (EpiSC) in that they expressed Klf4, Rex1 and Stella 
and most importantly, they could contribute to the formation of adult chimaeras and 
demonstrated germline competency. 
 Isolation of these authentic rat ES cells paves the way for gene targeting in 
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1.1 The rat model 
Over the last century the rat has become established as the leading biomedical 
model within a wide variety of disciplines, and as such, a large number of relevant 
inbred disease models exist that make it the researcher’s preferred choice of model 
for the study of human disease (Jacob, 1999). The rat has several advantages over 
other species. Its size lends itself to practical considerations of animal husbandry 
such as space and cost, yet it is large enough to allow sophisticated surgical 
techniques to facilitate phenotypic analysis and the taking of multiple samples, 
unlike the mouse. 
However, despite these advantages, in recent years the mouse has succeeded 
the rat as the preferred mammalian experimental organism. Whilst the mouse, due to 
its smaller size and shorter reproductive cycle, may be better suited with regard to 
animal husbandry, it is not readily suited to some investigations requiring 
microsurgical techniques. Rather, the increased popularity of mouse is largely due to 
advances in genetic manipulation made possible by the derivation and maintenance 
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1.2 Mouse ES cells 
1.2.1 Blastocyst formation 
Mouse ES cells are derived from the inner cell mass (ICM) of the pre-
implantation embryo (Brook and Gardner, 1997; Evans and Kaufman, 1981; Martin, 
1981). The ICM is formed at the first differentiation step during early mouse 
embryogenesis, when the sixteen-cell embryo undergoes compaction to form two 
distinct cell populations (Gardner, 1983; Johnson and Ziomek, 1981). The inner 
cells, which constitute the ICM, are smaller and more tightly packed than the outer 
cells, which become polarised and flatten to form the trophectoderm (TE). The TE is 
responsible for the subsequent formation of the blastocyst cavity, a fluid-filled cavity 
(Biggers et al., 1977; Borland et al., 1977). As the cavity grows it forces the ICM to 
one end of the embryo. At this stage the embryo is referred to as a blastocyst and the 
second differentiation step occurs in which the ICM differentiates into the epiblast 
and primitive endoderm. The primitive endoderm forms on the side of the epiblast 
facing the blastocyst cavity and further differentiates into visceral and parietal 
endoderm (Gardner, 1982). Whilst the trophectoderm and the visceral and parietal 
endoderms go on to contribute to the placental epithelium and yolk sac respectively, 
epiblast cells are responsible for contributing to all the tissues of the adult organism. 
For this reason, the cells of the ICM or epiblast are termed pluripotent. 
 
1.2.2 ES cell characteristics 
Whilst in vivo the cells of the ICM commit to differentiate, in vitro, ES cells 
are capable of prolonged self-renewal, whilst retaining their pluripotential state and 
the ability to differentiate and colonise all the tissues, including the germ line, when 
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transferred back into a host blastocyst (Beddington and Robertson, 1989; Bradley et 
al., 1984). 
 
1.2.3 ES cells as a research tool 
The characteristics of mouse ES cells have allowed for the generation of mice 
with designed genetic modifications. Using techniques such as gene targeting, 
specific and precise genetic alterations can be made to the genome of ES cells 
cultured in vitro that can then be introduced into the germ line for the study of 
phenotypic changes in vivo. Thus, genetic modification of ES cells has become the 
primary strategy for investigating mammalian gene function in vivo, and for 
modelling diseases. In addition, ES cells have been useful for unravelling the 
molecular mechanisms that control self-renewal and pluripotency. The ability to 
control the differentiation of ES cells in vitro into specific cell types has facilitated 
investigations into mechanisms of lineage-specific differentiation and in the future 
may provide the basis for regenerative therapies. Collectively, these capabilities have 
made ES cells an invaluable and essential tool to the researcher. 
  
1.2.4 ES cell derivation 
When ICMs are cultured in vitro under permissive conditions, the 
disaggregated outgrowths give rise to colonies of undifferentiated, pluripotent ES 
cells. Originally ES cells were derived and maintained in the undifferentiated state on 
a layer of mitotically inactivated fibroblasts (Evans and Kaufman, 1981; Martin, 
1981). Typically primary embryonic fibroblasts or immortalised cells such as STO 
cells are required to provide support for the growing ES cells. The nature of this 
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support may be multifactorial, such as improving attachment, by direct cell signalling 
effects, or by conditioning the medium with necessary factors. Whilst feeder cell-
conditioned medium demonstrated only limited ability to maintain ES cells and 
prevent differentiation, it was discovered that ES cells could be maintained 
independent of feeder cells in the presence of media conditioned by the Buffalo rat 
liver cell line (Smith and Hooper, 1987). It was later discovered that the key 
constituent responsible for ES cell maintenance in both these culture conditions was 
the polypeptide factor, leukaemia inhibitory factor (LIF) (Smith et al., 1988; 
Williams et al., 1988). Germ-line competent ES cells can be propagated and 
maintained independent of feeders whilst in the presence of LIF (Nichols et al., 
1990). However, in the absence of LIF, ES cells spontaneously differentiate. 
 
1.3 LIF signalling 
1.3.1 LIF/gp130/STAT3 
 LIF is a member of the IL (interleukin)-6-type family of cytokines that signal 
via the transmembrane receptor glycoprotein 130 (gp130). LIF binds to its low-
affinity receptor LIFR, which complexes with gp130 to form a high-affinity receptor 
(Davis et al., 1993; Gearing et al., 1992; Gearing et al., 1991). However, LIF 
receptor homozygous null (Lifr-/-) ES cells can be maintained in the presence of IL-6 
together with its soluble receptor, sIL-6R. The IL-6/sIL-6R complex signals via a 
gp130 homodimer, demonstrating that, gp130 and not LIFR, is the key signal 
transducer of LIF (Murakami et al., 1993; Yoshida et al., 1994). 
 The intracellular response of gp130 is initiated by Janus kinase (JAK). JAKs 
bind to the intracellular domain of gp130. Upon cytokine binding the receptor 
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undergoes a conformational change that brings the JAK molecules into close 
proximity to each other, resulting in their subsequent activation by auto- or trans-
phosphorylation. The activated JAKs then phosphorylate tyrosine residues of gp130 
that serve as binding sites for proteins containing Src-homology-2 (SH2) domains, 
which have a high affinity for phosphorylated tyrosine. STAT3 (signal transducer 
and activator of transcription 3) is one such protein (Stahl et al., 1995). 
 STATs are latent cytoplasmic transcription factors. They are recruited to 
activated receptors that have become activated by tyrosine phosphorylation in 
response to a variety of extracellular signals. Receptor-bound STAT is subsequently 
activated via a tyrosine kinase associated with the receptor, such as JAK (Ihle, 1996). 
This creates a further STAT3 docking site and thus mediates dimerisation of the 
molecule. Upon dimerising, the STAT3 molecules undergo a conformational change 
that releases them from the receptor, allowing their translocation to the nucleus 
whereby they can interact with the DNA to induce transcription of target genes. 
 It has been demonstrated that STAT3 activation by LIF is required for mouse 
ES cell self-renewal. Expression of a dominant negative STAT3 or mutation of the 
STAT3 docking sites on the gp130 receptor causes ES cells to differentiate even in 
the presence of LIF (Niwa et al., 1998), whilst an activatable STAT3-ER fusion 
supports ES cells self-renewal in the absence of LIF (Matsuda et al., 1999). 
Interestingly, LIF also activates the MAPK/Erk1/2 and PI3K signalling pathways, 
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1.3.2 Role of MAPK/Erk 
Mitogen-activated protein kinases (MAPK), or Extracellular signal-regulated kinases 
(Erk) as they were originally called, are involved in a wide range of cellular 
processes, such as cell motility, proliferation and differentiation, and are expressed, 
to varying extents, in all tissues (Binetruy et al., 2007). They are intracellular 
serine/threonine kinases that become activated in response to a host of different 
extracellular signals such as growth factors (e.g. FGFs) and cytokines (e.g. LIF) that 
initiate a series of phosphorylation events (Cowley et al., 1994). This 
phosphorylation cascade is initiated when the extracellular signalling molecule binds 
to its receptor resulting in phosphorylation of the receptor's tyrosine residues. This 
occurs either directly, due to intrinsic receptor tyrosine kinase activity, as in the case 
of the FGF receptor (Heldin, 1996) or indirectly, via their association with non-
receptor protein kinases such as JAK, in the case of gp130. 
 As mentioned earlier, these active tyrosine residues act as binding sites for 
proteins containing SH2-domains. In the case of Erk1/2 activation, the protein 
tyrosine phosphatase, SHP-2, is recruited to the receptor. SHP-2 can activate Erk by 
complexing with adaptor molecules such as Growth factor receptor-bound protein 2 
(Grb2). Grb2 consists of an SH2 domain and an SH3 domain (Lowenstein et al., 
1992). It binds to SHP-2 via its SH2 domain and couples this to Erk activation via 
the binding of the Ras GTP-GDP exchange protein, Son of Sevenless (SOS) to its 
SH3 domain (Egan et al., 1993; Gale et al., 1993; Li et al., 1993; Rozakis-Adcock et 
al., 1993). SOS increases the proportion of active, GTP-bound Ras leading to the 
downstream phosphorylation and activation of Erk. The targets of activated Erk are 
located throughout the cell, including the cytoplasm (e.g. p90/rsk) (Gavin and 
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Nebreda, 1999) as well as nuclear transcription factors (e.g. c-Myc) (Gupta, Seth et 
al. 1993).  
It has been demonstrated that Erk activation by LIF is dispensable for ES cell 
self-renewal. A mutant gp130 receptor that prevents SHP2 binding, fails to activate 
Erk1/2, yet continues to support ES cell self-renewal. This was supported by the 
maintenance of ES cells in the presence of the mitogen-activated protein kinase 
kinase (MEK) inhibitor PD098059 (Burdon et al., 1999). Not only did MEK 
inhibition enhance ES cell self-renewal it also inhibited embryoid body 
differentiation, suggesting that Erk signalling is necessary for lineage commitment of 
ES cells. 
 In vivo, Erk2-/- embryos fail to form mesoderm and die post-implantation due 
to trophoblast defects (Saba-El-Leil et al., 2003). Although Erk2-/- ES cells can be 
propagated in vitro, they are deficient in neural and mesoderm commitment (Kunath 
et al., 2007). The importance of Erk signalling for differentiation was further 
confirmed when it was demonstrated that only a short period of Erk activation is 
required to initiate neural specification (Stavridis et al., 2007). These findings 
demonstrate the importance of Erk signalling for the commitment of ES cells to 
differentiate. Therefore, the dual, yet conflicting activation of STAT3 and Erk by 
LIF, suggests the balance between these contributes toward ES cell maintenance.  
 
1.3.3 Role of PI3K 
LIF is also known to activate the class IA family of Phosphoinositide 3-kinase 
(PI3K). PI3Ks are involved in a wide range of cellular processes such as 
proliferation, cell migration, cell survival and trafficking. SHP-2 forms a complex 
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with PI3K via the adaptor molecule Grb2-associated binding protein 1 (Gab1) 
thereby translocating PI3K to the membrane, where it can act upon its substrate. 
 PI3K is a lipid kinase that phosphorylates the membrane 
phospholipid, phosphatidylinositol 3,4-bisphosphate (PIP2) to form 
phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 is capable of binding proteins 
containing a pleckstrin homology (PH) domain and in so doing is responsible for 
recruiting proteins to the membrane. One such protein is protein kinase B 
(PKB/AKT). Membrane-localised PKB/Akt activation relies on phosphorylation of 
both Thr308 by Phosphoinositide-dependent kinase I (PDK1) (Alessi et al., 1997; 
Stokoe et al., 1997), which is also localised to the membrane via its PH domain, and 
Ser473 by MTORC2, a complex containing mammalian target of rapamycin (mTOR) 
(Sarbassov et al., 2005). 
 The effect of the PI3K signalling pathway on mouse ES cells was first 
demonstrated through the discovery of the tumour suppressor Phosphatase and tensin 
homologue deleted on chromosome 10 (PTEN). PTEN is a lipid phosphatase which 
dephosphorylates PIP3 to PIP2 (Maehama and Dixon, 1998), essentially 
counteracting PI3K activity and preventing membrane localisation and activation of 
PKB/Akt and its subsequent downstream signalling. PTEN null (PTEN-/-) mice fail 
to survive beyond day E9.5, but demonstrate regions of enhanced growth. Similarly, 
PTEN-/- mouse ES cells exhibit an increased growth rate and enhanced ability to 
form teratomas (Di Cristofano et al., 1998; Stambolic et al., 1998). Increased levels 
of PKB/Akt phosphorylation and activation accompany this proliferative advantage, 
suggesting that PKB/Akt promotes ES cell proliferation and that it is negatively 
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regulated by PTEN. Furthermore, when the ubiquitously expressed PKB/Akt 
isoform, Akt-1, was also mutated in PTEN null cells, the observed growth advantage 
was reversed (Stiles et al., 2002). This effect on mouse ES cell proliferation was 
supported by the demonstration that the ES cell-expressed Ras (Eras) binds to and 
activates PI3K and that Eras-/- ES cells exhibited decreased cell growth and PKB/Akt 
phosphorylation. However, Eras-/- cells could generate viable animals demonstrating 
that it is not essential for ES cell pluripotency (Takahashi et al., 2003).  
 One downstream target of PI3K, which may mediate this proliferative effect, 
is the mammalian target of rapamycin (mTOR). mTOR appears to be ubiquitously 
expressed in most tissues, including mouse ES cells. Activation of P70-S6 kinase-1 
by mTOR, leads to an increase in protein synthesis and cell proliferation (Kawasome 
et al., 1998). mTOR deficient embryos die around E6.5-7.5 due to impaired 
proliferation and although null blastocysts appear normal, they fail to produce ES 
cells (Murakami et al., 2004). 
 These findings suggest the importance of PI3K in ES cell proliferation. 
However, there are also indications of an effect of PI3K on ES cell self-renewal. 
Differentiation was enhanced in the presence of the PI3K inhibitor, LY294002, or 
upon expression of a more specific dominant-negative PI3K subunit (Paling et al., 
2004). This appeared to be a direct result of enhanced Erk activation, since self-
renewal was restored upon addition of the MEK inhibitors PD98059 or U0126. 
 A constitutively active form of PKB/Akt could maintain mouse ES cells in 
the undifferentiated state independent of LIF (Watanabe et al., 2006). However, the 
downstream effector of PKB/Akt that is implicated in ES cell self-renewal remained 
unidentified. Storm et al demonstrated that PI3K inhibition resulted in a down-
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regulation of Nanog expression, a reduction in Nanog protein levels, and a loss of 
self-renewal (Storm et al., 2007). The loss of self-renewal by PI3K inhibition could 
be prevented by activation of an inducible Nanog. Furthermore, the group 
demonstrated that loss of Nanog and self-renewal was mediated by Glycogen 
synthase kinase 3 (GSK-3). Inhibition of GSK3 has been implicated in ES cell self-
renewal (Sato et al., 2004) and PKB/Akt-mediated phosphorylation inactivates GSK3 
(Cross et al., 1995). Indeed, Storm et al demonstrated that inhibition of GSK-3 
reversed the effect of PI3K inhibition and could maintain Nanog levels and self-
renewal (Storm et al., 2007). 
 
1.3.4 GSK3 
GSK3 is a constitutively active serine/threonine kinase that was initially 
demonstrated to phosphorylate and inactivate glycogen synthase, an enzyme 
responsible for polymerizing glucose molecules into glycogen for storage (Embi et 
al., 1980). GSK3 regulates its substrates by phosphorylating serine and/or threonine 
residues that typically results in their inhibition. Phosphorylation by GSK3 is 
significantly enhanced in proteins that are pre-phosphorylated, or ‘primed’ by 
another kinase (Doble and Woodgett, 2003). The primed phospho-residue binds to a 
positively charged pocket within GSK3. This correctly orients both the kinase 
domain and the substrate within the catalytic region for efficient phosphorylation. In 
the case of glycogen synthase inactivation, the enzyme is pre-phosphorylated, or 
primed, by casein kinase II (CK2) prior to undergoing GSK3-mediated multisite 
phosphorylation (Fiol et al., 1990). 
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 As it is constitutively active, regulation of GSK3 takes the form of inhibition. 
This occurs as a result of phosphorylation at serines 9 or 21 by an inactivating 
kinase. The mechanism of GSK3 inhibition takes advantage of its positively charged 
pocket’s preference for phospho-residues. As such the phosphorylated S9/21 residues 
act as pseudo-substrates, binding to the positively charged pocket and occupying the 
catalytic domain, thereby competing with genuine substrates. For example, in 
response to insulin, GSK3 is inactivated in a PI3K-dependent manner via 
phosphorylation by PKB (Cross et al., 1995). Although there are several regulators of 
GSK3, including PI3K/PKB and MAPK, probably the best studied is Wnt. 
 GSK3 plays a central and inhibitory role in the Wnt/β-catenin signalling 
pathway. In the absence of Wnt stimulation, GSK3 is in its active state and forms 
part of what is known as the ‘destruction complex’. The destruction complex consists 
of GSK3, Axin and adenomatous polyposis coli (APC) protein. Both Axin and APC 
are phosphorylated by GSK3, which increases and stabilises their binding to β-
catenin. Within this complex GSK3 phosphorylates β-catenin which initiates its 
ubiquitylation and subsequent proteosome degradation, thereby limiting the 
cytoplasmic pool of  β-catenin (Doble et al., 2007). Stimulation by Wnt activates the 
cell-surface receptor Frizzled that phosphorylates Dishevelled and subsequently 
prevents GSK3-mediated phosphorylation of β-catenin. As a result β-catenin 
accumulates within the cytoplasm and translocates to the nucleus where it can 
interact with T-cell factor (TCF)/ Lymphoid enhancer factor (LEF) transcription 
factors and regulate transcription of their downstream targets. 
 GSK3 exists as two homologues, GSK3α and GSK3β encoded by separate 
genes. Alleles of each homologue were sequentially knocked-out in mouse ES cells 
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to generate five lines (Doble et al., 2007). In both single homozygous knock-out 
lines, the level of β-catenin not altered. A gene dosage effect was demonstrated when 
either both alleles of one homologue and one of the other, or both alleles of each 
homologue were deleted. Therefore, with respect to the Wnt/β-catenin pathway, 
redundancy exists between GSK3α and GSK3β function. Although both ES cell 
morphology and expression of Oct4 and Nanog were maintained, GSK3α-/- and 
GSK3β-/- double knockout (DKO) cells also expressed the early mesoderm marker 
Brachyury, a TCF-responsive gene upregulated in response to increased levels of β-
catenin. In this regard, these cells are similar to early mesoderm–specified (EM) 
progenitors (Suzuki et al., 2006). Furthermore, the ability of GSK3α/β DKO cells to 
differentiate was severely restricted as demonstrated by their failure to generate 
cardiomyocytes in embryoid body (EB) assays and the absence of neural tissue in 
teratomas. The influence of GSK3 on ES cell differentiation supports other studies 
which suggest a role for GSK3 inhibition in maintaining ES cell self-renewal, 
whether directly (Sato et al., 2004) or indirectly via upstream regulation by 
PI3K/PKB (Paling et al., 2004; Storm et al., 2007) or stabilisation of downstream 
targets such as c-myc (Cartwright et al., 2005). 
 
1.3.5 c-Myc 
 A molecule that may reconcile the apparently conflicting downstream 
activities of LIF toward a common goal of ES cell maintenance is the transcription 
factor c-Myc. c-Myc is transcriptionally regulated by STAT3 and has been 
demonstrated to promote ES cell self-renewal by blocking differentiation (Cartwright 
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et al., 2005). Whilst STAT3 is involved in the transcriptional regulation of c-Myc, 
both Erk and PI3K are involved in its post-transcriptional regulation. 
 Degradation of c-Myc protein occurs following GSK3-mediated 
phosphorylation of Threonine 58 (T58). As a result, the protein is poly-ubiquinated 
and subsequently degraded by the proteosome. A stable form of c-Myc, in which the 
T58 residue is mutated, facilitates ES cell self-renewal independent of LIF 
(Cartwright et al., 2005). In the presence of LIF, Erk is activated and stabilises c-
Myc by phosphorylating Serine 62 (S62), a step that is also required to prime c-myc 
for GSK-mediated phosphorylation of T58. However, this activity of GSK3 is 
prevented by PI3K. 
 In short, LIF stimulation up-regulates c-Myc via STAT3 and stabilises c-Myc 
protein via Erk activation and subsequent S62 phosphorylation as well as PI3K 
blocking of GSK-mediated degradation. 
 
1.4 Intrinsic determinants 
1.4.1 Oct4 and Cdx2  
Oct4 is an octamer binding protein and member of the POU family of homeodomain 
transcription factors. Oct4 is maternally expressed, observed in the unfertilised 
oocyte, but not in sperm or testis. During development, expression progresses 
through the cleavage stage embryo becoming restricted to the pluripotent 
compartments of the developing embryo, namely the ICM of the blastocyst and 
epiblast of the egg cylinder. Expression of Oct4 is gradually downregulated after 
gastrulation (as cells are differentiated into somatic lineages) and becomes limited to 
primordial germ cells (PGC) (Scholer et al., 1990; Yeom et al., 1996). Intercrossing 
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mice heterozygous for an Oct4 deletion failed to produce any term or midgestation 
homozygous Oct4-deficient pups (Nichols et al., 1998). At E5.5, embryonic material 
was absent in 18 of 61 implantation sites analysed. Whilst E3.5 blastocysts appeared 
normal, with normal cell numbers, they failed to cavitate fully. Further expansion 
was not observed upon delayed implantation, rather, the embryos collapsed. 
Attempts to derive mouse ES cells from intact blastocysts or isolated ICMs of 
homozygous mutants yielded only trophoblast giant cells. Therefore, although Oct4-
deficient cells are viable, they fail to develop beyond an immature blastocyst in vivo 
or to generate ES cells in vitro, demonstrating that Oct4 is essential for establishment 
of a pluripotent ICM. Knockdown of Oct4 in mouse ES cells using siRNA (Hay et 
al., 2004) or a tetracycline-regulated transgenic system (Niwa et al., 2000) 
demonstrated differentiation into trophectoderm, confirming the importance of Oct4 
in maintaining ES cell self renewal. Interestingly, the precise level of Oct4 is critical. 
Not only does repression of Oct4 induce differentiation, but less than a two-fold 
over-expression induces differentiation into mesoderm and primitive endoderm 
(Niwa et al., 2000). Confocal imaging of immunohistochemical-stained embryos 
revealed that at the first differentiation stage during development, Oct4 protein 
becomes segregated to the ICM cells and is lost in surrounding trophectoderm 
(Palmieri et al., 1994). The primitive endoderm cells which evolve at the second 
differentiation step demonstrate higher levels of Oct4 than ICM cells. This data 
confirms that regulation of Oct4 protein levels determines three distinct cell 
populations leading to the formation of a mature blastocyst. 
 Whilst Oct4 is first downregulated in the trophectoderm, conversely, the 
Caudal-type homeobox transcription factor, Cdx2, is specifically expressed in the 
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trophectoderm of the blastocyst (Beck et al., 1995). Cdx2-/- embryos do not form a 
mature blastocoelic cavity or distinct epithelial outer layer and fail to implant 
(Strumpf et al., 2005). Interestingly, in wild type embryos, although Oct4 and Cdx2 
expression are segregated in the blastocyst and specify distinct cell populations, they 
are initially co-expressed in cells of the early embryo (Niwa et al., 2005; Strumpf et 
al., 2005). Immunohistochemical staining of Cdx2-/- blastocysts demonstrated ectopic 
Oct4 expression in cells of the trophectoderm, suggesting that Cdx2 is necessary to 
restrict Oct4 expression to the ICM (Strumpf et al., 2005). Niwa et al demonstrated 
that over-expression of Cdx2 induced trophectoderm differentiation even in the 
continued presence of transgenic Oct4 (Niwa et al., 2005). This suggests that Oct4 
cannot block Cdx2-induced trophectoderm differentiation, and that loss of Oct4 is 
not a pre-requisite for differentiation to proceed. 
 The fact that blastocysts develop in Oct4-/- and Cdx2-/- embryos, suggests that 
segregation of inner and outer layers is not dependent on either factor, but rather both 
are important for the specification of lineage identity, such that subsequent 
differentiation ensues correctly (Smith, 2005). 
 
1.4.2 Nanog 
 Nanog is a homeoprotein which, when overexpressed, is capable of mediating 
LIF-independent ES cell self-renewal. It was originally identified in two ways. The 
first employed a functional expression cloning strategy, using Lifr-/- ES cells in the 
absence of cytokine, to identify cDNAs that could maintain mouse ES cells 
independent of LIF (Chambers et al., 2003). The second utilised in silico differential 
display to compare expressed sequence tag (EST) libraries from mouse ES cells and 
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various somatic tissues to identify genes expressed in ES cells as specifically as 
Oct4. One of the nine candidates identified was then shown to facilitate LIF-
independent self-renewal upon forced expression (Mitsui et al., 2003). This protein 
was Nanog. 
 Nanog is endogenously expressed in ES cells and is downregulated upon 
differentiation. In fact, expression is confined to pluripotent cells, such as ES, 
embryonic germ (EG) and embryonic carcinoma (EC) cells, but is absent from adult 
tissues (Chambers et al., 2003; Mitsui et al., 2003). In vivo, expression first appears 
in the compacted morula where it is localised to the central compartment that will 
later become the ICM. Indeed, expression is confined to the ICM and epiblast of 
early and late blastocysts, but absent from the trophectoderm and primitive 
endoderm. By the implantation stage, expression is downregulated, but reappears at 
E11.5 in the genital ridges where staining is localised to the primordial germ cells 
(PGC) (Chambers et al., 2003).  
 Whilst endogenous levels of Nanog are required for maintaining self-renewal, 
ES cells are still reliant upon LIF signalling. LIF-independent self-renewal and 
resistance to differentiation are only mediated upon over-expression of Nanog. 
Interestingly, the self-renewing capacity of Nanog over-expressing ES cells is 
enhanced in the presence of LIF. However, Nanog does not appear to be a 
downstream target of LIF/gp130/STAT signalling, nor regulate STAT3 itself, 
suggesting that this combinatorial effect on self-renewal is a result of parallel action 
(Chambers et al., 2003). Likewise, Erk activation does not repress, nor is repressed 
by, Nanog. However, in the absence of Oct4, Nanog over-expressing cells 
differentiate, indicating that Oct4 expression is required for Nanog action. 
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 Sequential targeted disruption of the homeodomain in both alleles of the 
Nanog gene was performed to generate Nanog-deficient ES cells. These cells 
adopted a parietal endoderm-like morphology in the absence of feeder cells and 
expressed endoderm transcription factors GATA4 and GATA6, as well as parietal 
and visceral endoderm markers (Mitsui et al., 2003). Chambers et al also generated 
Nanog-/- ES cells by genetic deletion. By comparing Nanog+/+, Nanog+/- and Nanog-/- 
cells in a clonal assay, they demonstrated a stepwise reduction in the number of 
undifferentiated, alkaline positive colonies. Interestingly however, although prone 
toward differentiation, Nanog-/- cells were still capable of forming undifferentiated 
colonies (Chambers et al., 2007). In fact, in routine wild type ES cell cultures they 
observed that Nanog was undetectable in a fraction of Oct4-expressing cells. Using a 
Nanog-eGFP reporter cell line they demonstrated that levels of Nanog fluctuated in 
ES cell cultures. Although cells with no Nanog were predisposed toward 
differentiation, they did not commit, but rather remained undifferentiated and 
continued to express Oct4 and had the ability to re-express Nanog (Chambers et al., 
2007). Surprisingly, aggregation experiments demonstrated that Nanog-/- ES cells 
retain their pluripotent potential and are capable of contributing to adult chimaeras. 
However, whilst Nanog-null cells populate the genital ridges, PGC development 
appears to be prevented beyond E11.5 (Chambers et al., 2007). 
 The precise requirement for Nanog in the developing early embryo was 
further highlighted by breeding of Nanog heterozygous mice to generate Nanog-null 
embryos. Whilst Nanog heterozygous mice appeared normal and were viable, 
homozygous embryos at E5.5 were highly disorganised with no distinct epiblast. 
Interestingly E3.5 null blastocysts appeared normal, although ICMs could not be 
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maintained in vitro, but differentiated entirely into parietal endoderm-like cells 
(Mitsui et al., 2003). Overall, these data suggest that Nanog is neither required for 
the maintenance of pluripotency nor the integration of ES cells into the embryo, but 
rather for the establishment of pluripotency and germ cell formation. 
 The mechanisms through which Nanog functions are still incompletely 
understood. However, recent studies have indicated that Nanog exists in both 
monomeric and dimeric forms. Homodimers form via a tryptophan repeat region that 
acts as a dimerisation domain. Importantly, it was demonstrated that specific deletion 
or mutation of this region eliminates Nanog-Nanog interaction and the ability to 
mediate LIF-independent self-renewal (Mullin et al., 2008). It is unclear how 
dimerisation is regulated. Nonetheless, dimerisation is also likely to be important for 
the binding of Nanog to its protein partners and targets, and this will be affected by 
the differing binding specificities of monomeric and dimeric forms as well as their 
relative levels in vivo. 
 
1.5 ES cell derivation from other species 
1.5.1 Human ES cells 
Since the isolation of mouse ES cells nearly 30 years ago, derivation of 
comparable cell lines from other species has been largely unsuccessful, with the 
notable exception of human ES cells. Human ES (hES) cells  were originally derived 
from in vitro fertilised embryos in conditions very similar to those used for isolation 
of mouse ES cells (Thomson et al., 1998). In common with their mouse counterparts, 
hES cells are capable of self-renewing in vitro whilst retaining expression of the core 
transcription factors Oct4, Nanog and Sox2, and the capacity to differentiate into 
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cells of all three germ layers when injected into immuno-compromised mice. 
However, for ethical reasons it is unknown if these cells will fulfil the critical ESC 
cell requirement and contribute to germline-transmitting chimaeras. More 
importantly, there are some key differences between mouse and human ES cells with 
regard to the markers they express, the conditions in which they grow and the 
signalling pathways involved in their maintenance. 
 Whilst mouse ES cells express the cell surface marker SSEA1, human 
cells do not, but rather, express SSEA3 and SSEA4 as well as other cell surface 
markers such as TRA-1-60 and TRA-1-81. In this respect these cells more closely 
resemble human embryonic carcinoma cells (Andrews et al., 1996; Kannagi et al., 
1983). Furthermore, unlike mouse ES cells, hES cells are sensitive to single-cell 
passaging, which hinders clonal propagation and assays. Intriguingly, LIF, which is 
important for mouse ES cell self renewal, does not support hES cell growth, nor 
prevent differentiation in the absence of feeder cells or conditioned medium. 
Differentiation occurs despite the fact that hES cells express both LIFR and gp130, 
and demonstrate LIF-induced STAT3 phosphorylation (Daheron et al., 2004; 
Humphrey et al., 2004). The absence of STAT3 phosphorylation in undifferentiated 
hES cell cultures suggests that this pathway is not important for hES cell self-
renewal. However, culture in the complete absence of STAT3 signalling is necessary 
to determine that the role of STAT3 function is indeed redundant in hES cell 
maintenance. Similarly, BMP4, which assists in maintaining mouse ES cells in 
feeder/serum-free conditions by blocking neuroectoderm differentiation, (Ying et al., 
2003) has been demonstrated to induce trophectoderm differentiation in hES cells 
(Xu et al., 2002). 
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The key pathways involved in hES cell maintenance appear to be bFGF 
(FGF2) and TGFβ/Activin/Nodal. FGF2 at a concentration of 4ng/ml was 
demonstrated to enhance clonal expansion and long-term culture of hES cells in the 
presence of serum replacement medium (SR) (Amit et al., 2000). This medium could 
also support feeder-free growth of hES on MatrigelTM or laminin when previously 
conditioned by MEFs (CM) (Xu et al., 2001). In unconditioned medium, serum 
replacement medium induces BMP activity and rapid differentiation. BMP 
antagonists, such as Noggin, are detected in CM that protect against SR-induced 
differentiation. Interestingly higher levels of FGF2 (100ng/ml) reduce BMP 
signalling and maintain hES cells in unconditioned medium (UM) (Xu et al., 2005). 
It has been demonstrated that FGF2 degrades rapidly in UM compared to CM, such 
that only suboptimal levels of FGF2 exist, which are incapable of blocking 
differentiation. At higher concentrations, the critical threshold is achieved that 
facilitates self-renewal (Levenstein et al., 2006). Whilst these results have helped to 
define the hES cell culture conditions and demonstrate a specific role for FGF2, the 
culture still includes the addition of cell matrix and unrefined SR of animal origin, 
and does not provide evidence of any positive or negative effects these may have on 
hES cell self-renewal. 
Recently, the TGF/Nodal/Activin pathway has also been demonstrated to 
play a role in hES cell maintenance. TGFβ1, Nodal and Activin are members of the 
transforming growth factor beta (TGF-β) superfamily that modulate their 
intracellular signal via Smad2/3 phosphorylation (Shi and Massague, 2003). Amit et 
al demonstrated feeder- and serum-free culture of hES cells in medium composed of 
SR, FGF2, LIF and TGFβ1. Although individually, TGFβ1 (0.12ng/ml) and FGF2 
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(4ng/ml) could not efficiently maintain hES cells at the concentrations used, their 
combinatorial effect was comparable to feeder conditions (Amit et al., 2004). Whilst 
investigating the role of Nodal on modulating hES cell differentiation, Vallier et al 
demonstrated that forced transgenic expression of Nodal restricted differentiation 
during EB formation. Phenotypically distinct EBs formed which consisted of an 
outer layer of anterior visceral endoderm-like cells surrounding an inner core of cells 
that continued to express markers of undifferentiated hES cells (Vallier et al., 2004). 
When Nodal-expressing hES cells were grown on MEFs in a chemically defined 
medium (CDM) (Johansson and Wiles, 1995), without FGF or serum, they continued 
to express undifferentiated markers after six passages, whilst wild type cells 
differentiated. Indeed it was demonstrated that Nodal is endogenously expressed by 
hES cells and downregulated upon differentiation. However, inhibition of Nodal by 
Lefty (Meno et al., 1999) or Cerberus-Short (Piccolo et al., 1999) did not induce 
differentiation of hES cells on MEFs in SR medium (Vallier et al., 2005). This 
suggests that an alternative factor, also capable of activating Smad2/3, may be 
compensating. Further evidence that supported the importance of this pathway was 
demonstrated by addition of the TGF-β, Alk4/5/7 receptor inhibitor SB431542 to 
hES cell cultures, resulting in reduction of Smad2/3 phosphorylation and loss of Oct4 
protein (James et al., 2005). Indeed, Activin, which is produced by MEFs, was 
demonstrated to maintain hES cells in feeder and SR-free CDM in short-term 
cultures (Vallier et al., 2005). Long-term propagation however, required the addition 
of FGF2. Interestingly, the influence of FGF2 was blocked by SB431542, suggesting 
that it is dependent on Activin/Nodal signalling. Recent evidence has demonstrated 
that Smad2/3 can bind to the Nanog proximal promoter, the activity of which is 
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enhanced in response to Activin (Xu et al., 2008). A negative feedback may exist in 
which Activin-controlled expression of Nanog limits FGF-induced neuroectoderm 
differentiation and Smad2/3-induced endoderm differentiation, thereby maintaining 
pluripotency (Vallier et al., 2009). 
In conclusion, Activin/Nodal and FGF2 are required, at least in part, for the 
maintenance of hES cells, in defined, feeder and serum-free, conditions, although 
components of animal origin were still present in the attachment matrix and CDM -
which includes BSA. Whilst it was not demonstrated that these conditions could 
facilitate the de novo derivation of hES cells, they were recently demonstrated to be 
capable of deriving pluripotent stem cell lines from the post-implantation embryo of 
mouse and rat (Brons et al., 2007; Tesar et al., 2007). This further strengthens the 
belief that hES cells are distinct from their ICM-derived, mES cell counterparts and 
represent a developmental state equivalent to the late epiblast. Since the comparative 
developmental state of the cells of the ICM in mouse and human is unknown, the 
effect of similar culture conditions on the intrinsic state of these cells may differ. 
 
1.5.2 Rat ES-like cells 
Whilst ES cell derivation is routine for mouse strains such as 129/Ola, the 
degree of success varies greatly for other mouse strains, with some strains being 
refractory to derivation.  
Although ES-like cell lines have been established from a vast number of 
different species (Li et al., 2003; Saito et al., 2002; Sukoyan et al., 1992; Sun et al., 
1995; Tian et al., 2006), including the rat (Buehr et al., 2003; Iannaccone et al., 1994; 
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Ruhnke et al., 2003; Vassilieva et al., 2000), none as yet fulfil the necessary criteria 
to be deemed authentic ES cells. 
 These rat ES-like cells self-renew in vitro, are morphologically similar to 
mouse ES cells and express markers commonly, but not specifically, found in ES 
cells, such as Alkaline Phosphatase (AP) and SSEA1. However, they fail to maintain 
significant levels of the key ES cell transcription factor, Oct4, demonstrate limited or 
unconvincing differentiation capacity, and fail to contribute to the germline. Since 
the level of Oct4 is critical for the maintenance of pluripotency (Niwa et al., 2000), it 
is likely that appropriate expression of Oct4 throughout the derivation process is 
required. To investigate this, Buehr et al tracked Oct4 expression during the 
derivation process by generating transgenic rats in which the reporter construct 
lacZ/neomycin was under the control of the Oct4 promoter and enhancers (Buehr et 
al., 2003). Using typical mouse ES cell-derivation protocols, they demonstrated that, 
whilst Oct4 is expressed within the rat ICM, it is downregulated within the first few 
days during the derivation process. Importantly, this downregulation occurs with no 
obvious cell death, differentiation or morphological change, such that Oct4-negative 
and Oct4-positive cells are indistinguishable. This pattern of Oct4 downregulation 
was also observed in cultures of mouse ICMs for the strains CBA, MF1, C57BL/6 
and 129. After 5-6 days, Oct4 expression was diminished or absent in both rat and 
mouse outgrowths, with the exception of 129, which gave rise to Oct4-positive 
colonies. 
 After 6 days, morphologically undifferentiated, Oct4-negative rat outgrowths 
could be propagated and the resultant lines maintained in vitro. Although the cells 
are resistant to enzymatic digestion, they could be routinely mechanically passaged 
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by trituration. Propagation of these cells is reliant, not only upon the presence of a 
feeder layer and LIF, but also on the addition of MatrigelTM. Matrigel is a 
commercially available preparation that consists of a gelatinous protein mixture 
secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells that resembles 
tissue extracellular matrix and whose major components are laminin and collagen IV. 
Similar to most ES cell-like cells, they express AP and SSEA1, but fail to 
maintain Oct4. They also failed to generate chimaeras or contribute to either adult or 
fetal tissues as determined by microsatellite analysis. Interestingly, they strongly 
express the trophectoderm markers Cdx2 and CyclinD3, and when cultured in 
conditions for trophoblast stem (TS) cell derivation, are capable of forming colonies 
resembling mouse TS cells. They can also spontaneously give rise to parietal 
endoderm and are thus believed to be extra-embryonic in nature and as such, have 
been termed Extra-embryonic Stem (ExS) cells to distinguish them from true ES 
cells.  
This data demonstrates that upon exposure to typical in vitro ES cell culture 
conditions, Oct4 is readily extinguished from the explanted embryonic pluripotent 
cell population. Only the permissive mouse strain 129 can maintain Oct4 expression 
and generate ES cell lines. Although these Oct4-negative cells continue to proliferate 
without any obvious morphological change, the resultant cell lines have restricted 
developmental potential. This suggests that maintaining expression of Oct4, or 
protecting it from downregulation during the early stages of ES cell derivation, is 
critical for establishing true pluripotent ES cells 
Recently one group claimed to have established Oct4-expressing rat ES cell 
lines capable of forming chimaeras (Ueda et al., 2008). The data in support of this 
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finding are limited. Characterisation of the cells demonstrated that they did not 
express AP, and although they expressed SSEA-1, they also expressed markers 
common to hES cells, but not mouse ES cells, such as SSEA-3, SSEA-4 and TRA-1-
81. Whilst real-time PCR detected Oct4 and Nanog expression, the levels varied 
widely between lines and from those of mES cells. No other markers were examined 
to confirm the uncommitted state of the cells, such as Rex1 or FGF5. 
The differentiation potential of the cells was tested by embryoid body 
differentiation as well as teratoma formation by injecting cells into Severe Combined 
Immunodeficient (SCID) mice. Immunohistochemical staining of in vitro 
differentiated cells was either sparse (as for α-SMA) or failed to demonstrate the 
morphological features typical of the differentiated cell type, such as neuronal 
processes (as for β-III-tubulin). Whilst teratomas formed in vivo, it was reported that 
no structures of ectodermal origin were found and only intestinal epithelium-like and 
cartilage-like structures were identified. 
Contribution of these cells to chimaeric animals was reported, but 
surprisingly the strain combination of cells and host embryo used did not facilitate 
identification by either coat-colour transmission or microsatellite analysis. Rather 
confirmation relied upon PCR detection of a GFP transgene. Whether or not these 
cells are indeed capable of chimaeric contribution, the evidence provided is not 
thorough enough to convince the reader of their authenticity. Furthermore, the 
authors fail to demonstrate germline transmission or efficient in vitro differentiation 
protocols that are necessary for such cells to be fully utilised. 
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1.5.3 Epiblast Stem Cells (EpiSC) 
Recently, pluripotent stem cells have been derived from the epiblast of post-
implantation stage embryos of both mouse (E5.5-6.5) and rat (E7.5) using chemically 
defined medium containing activin (Brons et al., 2007; Tesar et al., 2007). These 
have been termed Epiblast Stem Cells (EpiSC) based on their tissue of origin and to 
distinguish them from ICM-derived ES cells. Interestingly, lines could also be 
efficiently derived from strains which are typically non-permissive for mouse ES cell 
derivation, such as NOD and CBA x C57BL/6. EpiSC can be continually passaged 
whilst retaining expression of Oct4, Nanog and Sox2 and the ability to differentiate 
into the three germ layers, as determined in vitro and in vivo, by embryoid body and 
teratoma formation respectively. 
 However, EpiSC differ in several ways from ES cells. The colonies are flatter 
in appearance and, unlike mouse ES cells, are sensitive to single cell dissociation. 
Examination of the expression profile revealed that, unlike ES cells, EpiSC failed to 
express the specific ICM marker Rex1, as well as having lower levels of other ICM-
associated genes, such as Gbx2, Pecam1 and Tbx3. Rather, they expressed higher 
levels of genes associated with the late epiblast and commitment, such as Fgf5, 
Gata6, and Sox17. However, following blastocyst injection, only two mouse 
chimaeras were born from 385 injected blastocysts. Although this may be a 
consequence of the requirement for cells to be single cell, morula aggregation 
experiments with clumps of cells failed to demonstrate any integration. 
 Furthermore, EpiSC cannot be propagated using ES culture conditions 
containing LIF and/or BMP4. Using the activin receptor inhibitor, SB431542, it was 
demonstrated that the presence of Activin is critical for the maintenance of EpiSC. 
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However, cultures were further improved by the addition of FGF2 - conditions which 
had previously been demonstrated to facilitate the long-term maintenance of human 
ES cells (Vallier et al., 2005). Conversely ICM cells differentiate when cultured in 
EpiSC conditions. 
 These data suggest that ES cells and EpiSC are distinct cell types 
representative of the tissue from which they were derived, namely the ICM and 
epiblast respectively. The inefficiency of EpiSC to contribute to chimaeras restricts 
their utility for generation of genetically engineered models. However, this 
inefficiency may be due to an incompatibility between the post-implantation origin 
of the cells with the pre-implantation environment of the host ICM cells, rather than 
an inherent deficiency of the cells themselves. 
 Intriguingly, EpiSC share several similarities with hES cells that are distinct 
from those of mouse ES cells, such as a dependence on Activin signalling, their 
sensitivity to single cell dissociation and BMP4-induced differentiation into 
trophectoderm. Comparison of the Oct4 targets within mouse ES cells, hES cells and 
EpiSC demonstrated a greater overlap of hES cells with EpiSC than with mES cells 
(Tesar et al., 2007). Therefore, hES cells may represent a later developmental stage 
than their mouse counterparts indicating either a difference in the starting cell 
population and/or a differing response to the culture conditions to which they are 
exposed. Recent findings have demonstrated the reversion of mouse EpiSC to ES 
cells by either a combination of ectopic Klf4 expression and LIF culture conditions 
or indeed LIF signalling alone (Bao et al., 2009; Guo et al., 2009). In addition 
conventional hES cells can be converted to a ‘naïve’ mouse ES cell state as a result 
of ectopic expression of Oct4, Klf2 and Klf4 in defined medium containing LIF 
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(Hanna et al., 2010). These results suggest that distinct states of pluripotency exist 
that are dependent on culture conditions and/or ectopic expression of key 
transcription factors, and that these conditions are dictated by species or strain 
specific requirements. 
 
1.6 Defined culture conditions 
 An understanding of the precise cues and mechanisms that direct self-renewal 
and initiate differentiation into specific lineages is complicated and hindered by the 
complexity of the culture conditions and the conflicting negative and positive 
influences. There are at least two contributing sources of unknown variables in ES 
cell cultures; feeder cells and serum. Serum is an undefined complex mixture derived 
from blood, consisting of growth factors and a host of other components. Whilst 
feeder cell metabolism may affect ES cells indirectly by competing for nutrients in 
the medium and altering the metabolite, pH and O2/CO2 levels, they can also exert an 
influence directly via cell-to-cell signalling or paracrine signalling, by releasing 
factors into the medium. Dissecting the effect any of these may have in ones culture 
system is daunting. Defining the medium, by reducing the composition to a minimal 
core of identified essentials, will highlight key requirements for ES self-renewal and 
facilitate our understanding of pluripotency, differentiation and development, as well 
as aiding regenerative medicine and pharmaceutical research by eliminating animal-
sourced factors. Even if a common mechanism exists which will establish ES cells 
from different species, failure to derive ES cells, even from species closely related to 
the mouse such as rat, suggests that subtle developmental or intrinsic differences 
exist which, when exposed to such undefined conditions, may prevent the necessary 
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status being established. Understanding the minimal essential pathway(s) may 
facilitate this or at least aid in delineating the key differences. 
 
1.6.1 LIF+BMP4 
 Whilst it has been demonstrated that LIF/STAT3 can facilitate derivation and 
propagation of mouse ES cells independent of feeders (Matsuda et al., 1999; Nichols 
et al., 1990; Niwa et al., 1998; Smith et al., 1988; Williams et al., 1988), culture in 
serum-free N2B27 induces efficient neuroectoderm differentiation. Although neural 
differentiation is reduced by the addition of LIF, ultimately it cannot be prevented 
(Ying et al., 2003). 
 Bone morphogenetic protein 4 (BMP4) is a member of the TGFβ superfamily 
known to suppress neural differentiation (Tropepe et al., 2001; Wilson and Hemmati-
Brivanlou, 1995). In feeder-free, serum-free culture and in combination with LIF, 
BMP4 blocks neural differentiation, facilitating ES cell self-renewal. The role of 
BMP4 in ES cell maintenance is somewhat surprising as it is involved in 
differentiation and patterning in the developing embryo (Jones et al., 1991). Indeed, 
in the absence of LIF, BMP4 induces ES cells to differentiate into non-neural, 
flattened epithelial-like cells. Therefore, BMP4 can substitute for serum by blocking 
neural differentiation, but is dependant upon LIF-mediated blockade of BMP4-
induced non-neural differentiation (Ying et al., 2003). These observations extended 
to BMP2 as well as the BMP relative Growth and Differentiation Factor 6 (GDF-6), 
but not to other members of the TGFβ superfamily, TGFβ1 or Activin. 
 BMP4 activates Inhibitor of Differentiation (Id) genes via the Smad 
signalling pathway (Ying et al., 2003). Indeed, overexpression of Id1, 2 or 3 negates 
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requirement for BMP4, whereas, overexpression of inhibitory Smads 6/7 impairs 
self-renewal and increases neural differentiation. This occurs even in the presence of 
serum and LIF, suggesting that induction of Id genes via Smad signalling is activated 
in ES cells by serum. Interestingly, ES cells express BMP4 as well as BMP receptors 
(BMPR) indicating that they have the potential to mediate autocrine signalling. If 
autocrine BMP4 signalling occurs, it appears to have only limited capacity to 
mediate self-renewal in serum-free conditions. This suggests that the presence of 
BMP4 or other BMPR ligand in serum is a key contributory factor such that serum-
free cultures require the addition of exogenous BMP4. 
 BMP4/Smad/Id does not appear to act by regulating gp130 signalling as 
STAT3 phosphorylation is not enhanced nor is Erk phosphorylation inhibited by 
BMP4 (Ying et al., 2003). Rather, the antagonistic activity of BMP4 on neurogenic 
basic helix-loop-helix (bHLH) transcription factors, such as Mash1, which are 
expressed in ES cells, may play a role in blocking neural differentiation. 
 
1.7 Aim 
 The derivation of mouse ES cells, combined with the ability to manipulate 
their genome in vitro, has facilitated the generation of disease models in mice. 
Although mouse ES cells have become a valued tool, there are occasions where other 
species would serve as more appropriate models. However, despite significant 
progress towards understanding the signalling pathways and intrinsic determinants 
involved in the formation of pluripotency in vivo and its maintenance in vitro, there 
has been limited success in deriving ES cells from other species. 
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 As discussed in this Chapter, the rat is a well established scientific model for 
which a large number of inbred disease models exist. The size of the rat favours 
microsurgery, sampling and phenotypic analysis, all of which are restricted in mouse. 
Furthermore, the rat is more intelligent than the mouse and is commonly used in 
studies of behaviour, cognition and memory. The failure to derive genuine rat ES 
cells capable of germline transmission is a major obstacle toward implementing 
genome modification in this species and suggests that unrefined culture conditions 
are unsuitable for capturing pluripotent rat ES cells.  
 The aim of this project was to generate and characterise authentic rat ES 
cells. A strategy was employed to reprogramme rat ES-like (ExS) cells by stable 
integration and expression of Oct4 and Nanog expression vectors. Also, a recently 
developed defined culture condition established for mouse ES cells that employed 
small molecule inhibitors of MEK and GSK3, had been applied to rat ES cell 
derivation protocols and this project concludes with the characterisation of the lines 
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Chapter 2 
Materials and Methods 
 
2.1 Materials 
2.1.1 General solutions 
 
Annealing buffer (x2)  200mM KOAc 
    60mM HEPES-KOH, pH 7.4 
    4mM MgOAc 
 
AP Buffer   100mM NaCl 
(Alkaline Phosphatase) 50mM MgCl2 
    0.1% Tween-20 
    100mM Tris pH 9.5 
 
BCIP    50mg/ml w/v in 100% DMF  
(5-bromo-4-chloro-   (N,N-dimethyl formamide) 
3-indoyl-phosphate)  
 
Denaturing solution  1.5M NaCl 
    0.5M NaOH 
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GTE    50mM Glucose 
    10mM EDTA, pH 8.0 
    25mM Tris-HCl, pH 8.0 
 
HB    50% v/v Formamide 
    5 x SSC pH 4.5, with citric acid 
    50µg/ml Heparin 
    0.1% v/v Tween 20 
 
Laemmli buffer (x2)  125mM Tris, pH 6.8 
(stock solution)  25% v/v Glycerol 
    4% v/v SDS 
 
Laemmli buffer (x1)  2x Laemmli buffer 
(working solution)  100mM DTT 
    Diluted with protease inhibitor-treated water 
    (1 tablet/3.5ml water) (Roche, 11 836 153 001) 
 
LB agar   1% w/v Bacto-tryptone (Difco, 211705) 
    0.5% w/v Bacto-yeast extract (Difco, 212750) 
    1% w/v NaCl 
    1.5%  w/v Bacto-agar (Difco, 214010) 
    to pH 7.0 then autoclave. 
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LB medium   1% w/v Bacto-tryptone (Difco, 211705) 
    0.5% w/v Bacto-yeast extract (Difco, 212750) 
    1% w/v NaCl 
    to pH 7.0 then autoclave. 
 
Lysis buffer (Tissue)  100mM Tris-HCl, pH 8.5 
    5mM EDTA, pH 8.0 
    0.2% w/v SDS 
    200mM NaCl 
 
NBT    75mg/ml in 70% w/v DMF (N,N-dimethyl formamide) 
(4-nitroblue tetrazolium) 
 
Neutralising solution, pH8 3M NaCl 
    0.5M Tris 
 
PBS    137mM NaCL 
    2.7mM KCL 
    4.3mM Na2HPO4 
    1.47mM KH2PO4 
    pH to 7.4 
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PBST    PBS 
    0.1% v/v Tween-20 
 
PFA (4%)   4% w/v in PBS, dissolved at 70oC for 2 hour 
 
PG-PBT   4% w/v PFA 
    0.2% v/v Glutaraldehyde in PBT 
 
RIPA    150mM NaCl 
    1% v/v Nonidet-P-40 
    0.5% w/v Sodium deoxycholate 
    0.1% w/v SDS 
    1mM EDTA 
    50mM Tris, pH 8.0 
 
SSC (20x)   3M NaCl 
    0.3M Sodium Citrate 
    to pH 7.0 with HCl 
 
SSC-FT   2x SSC, pH 4.5 
    50% v/v Formamide 
    0.1%  v/vTween-20 
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TAE (50x)   2M Tris 
    50mM EDTA 
    to pH 7.7 with acetic acid 
 
TBST (10x stock)  8g NaCl 
    0.2g Kcl 
    25ml 1M Tris pH7.5 
    10ml 10% v/v Tween-20 
 
TE buffer   10mM Tris-HCl, pH 8.0 
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2.1.2 Cell culture solutions 
 
3i medium   N2B27 medium 
    3µM CHIR99021 (Dundee University) 
    0.8µM PD184352 (Dundee University) 
    2µM SU5402 (Calbiochem, 572630) 
    Penicillin (100U/ml)  (Gibco,  
    Streptomycin (100µg/ml) 15140-122) 
 
2i Medium   N2B27 medium 
    3µM CHIR99021 (Dundee University) 
    1µM PD032 (Dundee University) 
    Penicillin (100U/ml)  (Gibco,  
    Streptomycin (100µg/ml) 15140-122) 
 
DMEM   1x DMEM (high glucose) (Gibco, 11965-092) 
    10% v/v FCS (Invitrogen, 10270-106) 
    2mM L-glutamine (Invitrogen, 25030-024) 
    1x Non-Essential Amino Acids (Gibco, 11140-035) 
    Penicillin (100U/ml)  (Gibco,  
    Streptomycin (100µg/ml) 15140-122) 
 
Freezing mix (2x)  N2B27/DMEM or GMEM + 10% v/v FCS 
    20% v/v DMSO 
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GMEM  1x GMEM (Sigma, G5154) 
   0.1mM Non-essential amino acids (Invitrogen, 11140-035) 
   2mM L-Glutamine (Invitrogen, 25030-024) 
   1mM Sodium pyruvate (Invitrogen, 11360-039) 
   β-mercaptoethanol (BDH, 44143-3A) 
   100U/ml LIF 
 
KSOMAA  KSOM dissolved in diluent (Chemicon, MR-020P-5D) 
   0.8x MEM non-essential amino acids (Sigma, M-7145) 
   1x BME amino acids (Sigma, B-6766) 
   5.56mM Glucose 
 
LIF   Recombinant LIF was produced by Cos7 cells that had  
   been transfected with the pC10-6R human DIA/LIF  
   expression vector (Smith, Heath et al. 1988). The Cos7  
   conditioned medium was harvested and the concentration  
   assayed using the mouse ES cell line, CP1, as indicator cells  
   (Rathjen, Toth et al. 1990) then diluted to give a stock  
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Lysis buffer (ES cell)  100mM Tris-HCl, pH8.5 
    5mM EDTA, pH8.0 
    2% w/v SDS 
    200mM NaCl 
 
N2 supplement  DMEM/F12 (Gibco, 21331-020) 
    50µg/ml BSA 
    25µg/ml Insulin 
    6ng/ml Progesterone 
    16µg/ml Putrescine 
    30nM Sodium Selenite 
    100µg/ml Transferrin 
 
Neurobasal/B27  Neurobasal medium (Gibco, 21103-049) 
    2% v/v B27 (Gibco, 17504-044) 
    L-glutamine (Invitrogen, 25030-024) 
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PB1    136.98mM Sodium chloride 
(Phosphate-buffered  2.73mM Potassium chloride 
medium)   0.3mM Sodium pyruvate 
    1.42mM Potassium dihydrogen phosphate 
    0.48mM Magnesium chloride 
    8.05mM Sodium hydrogen phosphate 
    0.94mM Calcium chloride 
    0.01mg/ml Phenol Red 
    1mg/ml Penicillin G 
    0.05mg/ml Streptomycin 
    1mg/ml Glucose 
    3mg/ml BSA 
 
RCGM   GMEM 
    15% v/v FCS (Invitrogen, 10270-106) 
    Penicillin (100U/ml)  (Gibco,  
    Streptomycin (100µg/ml) 15140-122)  
    200U/ml LIF 
 
Trypsin   0.025% w/v Trypsin (Invitrogen, 15090-046) 
    1mM EDTA 
    1% v/v Chicken serum (Sigma, C5405) 
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2.2 Cloning 
 Cloning of DNA fragments was achieved by ligating purified, restriction 
enzyme-digested DNA. DNA was digested with the appropriate restriction enzyme 
according to the manufacturer’s instructions. Digested DNA was resolved on a TAE 
agarose gel to confirm digestion, and the desired fragment excised then purified 
using Geneclean II gel purification kit (Qbiogene, 1001-400) according to the 
manufacturer’s instructions. Purified DNA concentrations were determined by TAE 
agarose gel electrophoresis alongside known standards. Typically a 3:1 insert:vector 
molarity ratio was ligated with 400U T4 DNA Ligase (NEB, M0202L) in a 20µl 
reaction overnight at 16oC. 
 
2.2.1 TOPO® Cloning 
 4µl of PCR products were cloned into the pCRII®-TOPO® vector using the 
TOPO® TA Cloning kit as manufacturer's instructions (Invitrogen, K4600-01). 
 
2.2.2 Transformation of bacterial cells 
 Typically 50ng vector DNA or 20µl of ligation reaction were transformed 
into 100µl DH5α competent cells. The DNA/cell mixture was incubated on ice for 30 
minutes prior to heat-shocking for 1 minute at 42oC. The cells were allowed to 
recover on ice for 2 minutes before adding 800µl LB medium and incubating for 1 
hour at 37oC with shaking. Various amounts of culture were plated on to 9cm LB 
agar dishes, allowed to absorb at room temperature and then incubated overnight at 
37oC. Dishes were stored at 4oC and colonies picked into LB medium containing the 
appropriate selective agent (typically 50µg/ml Ampicillin (Roche, 10835269001)). 
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2.3 Sample preparation 
2.3.1 Plasmid vector DNA isolation (miniprep) 
 A single bacterial colony was picked and used to inoculate a culture of 3ml 
LB medium containing appropriate antibiotic selection (typically 50µg/ml Ampicillin 
(Roche, 10835269001)). The culture was incubated for 16 hours at 37oC with 
shaking. 1ml of cell culture was harvested by centrifugation at 16,000g on a bench-
top centrifuge (Hereaus Biofuge Pico) for 2 minutes. The supernatant was discarded 
and the pellet resuspended in 100µl cold GTE by vortexing. The cell suspension was 
lysed by addition of 200µl 0.2M NaOH / 1% SDS (w/v), mixed by inversion and 
incubated on ice for 5 minutes. The lysate was then precipitated by addition of 150µl 
3M NaOAc, pH4.8, mixed by inversion and centrifuged at 16,000g for 10 minutes. 
The supernatant was transferred to 1ml of ice-cold 100% ethanol, mixed by inversion 
and spun at 16,000g for a further 10 minutes. The pellet was resuspended in 300µl 
0.1M NaOAc / 50mM Tris, pH 8.0 and incubated at 70oC for 10minutes. After 
cooling to room temperature, 5µl of 10mg/ml RNaseA (Roche, 10109169001) was 
added, mixed by inversion and incubated at room temperature for 1 hour. 300µl 
Phenol was added, vortexed and spun at 16,000g for 2 minutes. The aqueous phase 
was transferred to a fresh tube to which 300µl Chloroform was added, vortexed and 
spun for a further 2 minutes. DNA was then precipitated from the aqueous phase by 
addition of 750µl 100% ice-cold ethanol and centrifugation at 16,000g for 10 
minutes. The DNA pellet was washed twice with 70% ethanol, then air-dried and 
resuspended in 50µl TE buffer. 
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2.3.2 Plasmid vector DNA isolation (maxiprep) 
 A single bacterial colony was picked and used to inoculate a starter culture of 
3ml LB medium containing the appropriate antibiotic selection (typically 50µg/ml 
Ampicillin (Roche, 10835269001)). The culture was incubated for approximately 7 
hours at 37oC with shaking then pelleted by centrifugation at 1500g for 3 minutes 
(MSE Mistral 2000). The resultant pellet was resuspended in LB medium then used 
to seed a 250ml LB culture containing the appropriate antibiotic selection. The cell 
culture was incubated for 16 hours at 37oC with shaking then harvested by 
centrifugation at 6000g, 4oC for 10 minutes (Sorvall SLA-1500 rotor). The 
supernatant was discarded and the pellet resuspended in 10ml cold GTE by pipetting. 
The cell suspension was lysed by addition of 20ml 0.2M NaOH / 1%SDS, mixed by 
inversion then incubated on ice for 5 minutes. The lysate was then precipitated by 
addition of 15ml 3M NaOAc, pH4.8, mixed by inversion and spun at 2000g for 10 
minutes (MSE Centaur 2). The supernatant was divided equally into two 50ml 
Corning tubes and 25ml ice-cold Isopropanol added to each, mixed by inversion then 
centrifuged at 2000g for 10 minutes. Each pellet was resuspended in 1ml TE buffer, 
pooled, then 2.5ml of 5M LiCl added and mixed by inversion before centrifugation at 
2000g for 10 minutes. The supernatant was transferred to 12.5ml of ice-cold 100% 
ethanol, mixed by inversion then centrifuged again at 2000g for 10 minutes. The 
pellet was resuspended in 500µl TE buffer then transferred to a 1.5ml eppendorf 
tube. 20µl of 10mg/ml RNaseA was added, mixed by inversion and incubated at 
room temperature for 1 hour. 500µl of 1.6M NaCl / 13% PEG 6000 was added, 
mixed by inversion, incubated on ice for 5 minutes then centrifuged at 16,000g for 5 
minutes (Hereaus Biofuge Pico). The pellet was resuspended in 500µl TE buffer by 
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vortexing. 500µl Phenol was added, vortexed, then spun for 2 minutes at 16,000g. 
The aqueous phase was transferred to a fresh tube to which 500µl Chloroform was 
added, vortexed, then spun for a further 2 minutes. The aqueous phase was then 
precipitated in 1ml ice-cold 100% ethanol containing 50µl 3M NaOAc, pH5.5 by 
centrifugation at 16,000g for 10 minutes. The pellet was washed twice with 70% 
ethanol, then air-dried and resuspended in 500µl TE buffer. 
 
2.3.3 ES cell genomic DNA isolation 
 Cells were lysed in 500µl ES cell lysis buffer containing 50µg Proteinase K 
(Sigma, P2308) for 4-24 hours at 37oC. 500µl of room temperature Isopropanol was 
added and mixed by inversion for 10 minutes then centrifuged at 16,000g (Hereaus 
Biofuge Pico centrifuge). The pellet was washed twice with 70% ethanol then 
resuspended in 50µl TE buffer. 
 
2.3.4 Tail and ear genomic DNA isolation 
 Tissue samples were lysed in 500µl tissue lysis buffer containing 500µg 
Proteinase K (Sigma, P2308) overnight at 55oC. The lysates were cleared of debris 
by centrifugation at 9500g for 5 minutes, then transferring the supernatant to a fresh 
tube. The supernatant was then extracted, firstly with an equal volume of 
Phenol:Chloroform:Isoamylalchohol (25:24:1) and then Chloroform, by vortexing 
and then centrifuging at 9500g for 2 minutes. The final aqueous phase was 
precipitated in 2 volumes of ice-cold, 100% ethanol and 1/10th volume 3M NaOAc. 
The pellet was washed twice with 70% ethanol, air-dried and resuspended in TE 
buffer. 
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2.3.5 Blood cell genomic DNA isolation 
 Blood samples were centrifuged at 380g for 3 minutes (Hereaus Biofuge Pico 
centrifuge). The pellet was reusupended in 1ml Pharmlyse (BD Biosciences, 
#555899) and incubated in the dark for 15 minutes at room temperature. This was 
then centrifuged as before and the pellet resuspended in 500µl tissue lysis buffer 
containing 500µg Proteinase K (Sigma, P2308) overnight at 55oC. The lysates were 
then processed as for tail and ear samples. 
 
2.3.6 Protein isolation. 
 Cells were pelleted at 300g for 3 minutes (Eppendorf 5702 centrifuge) then 
washed with 5ml cold PBS. The final pellet was resuspended in 50µl 1x Laemmli 
buffer, sonicated (Branson sonifier 150, remote setting 2) until the lysate was no 
longer viscous (typically 2-5 second) then boiled for 10 minutes before storing at -
20oC. 
 
2.3.7 RNA isolation 
 Cells were pelleted at 300g for 3 minutes (Eppendorf 5702 centrifuge) then 
washed with 5ml cold PBS. The resultant pellet was stored at -80oC. RNA samples 
were isolated from cells using RNeasyTM Mini Kit (Qiagen, #74104) as detailed in 
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2.3.8 cDNA synthesis 
 cDNA was synthesized from RNA samples by Oligo-dT priming using the 
SuperscriptTM First Strand Synthesis System for RT-PCR (Invitrogen Corporation, 
#11904-018) as detailed in the manufacturer’s instructions. 
 
2.4 Detection methods 
2.4.1 Western Blotting 
 Samples were boiled for 5 minutes prior to running on a 10% Bis-Tris 
polyacrylamide gel (Invitrogen Corporation, #NP0301BOX). The gel was 
electrophoresed for 50 minutes at 200V in MOPS-SDS running buffer (Invitrogen 
Corporation, #NP0001) then transferred on to Immobilon-PTM PVDF membrane 
(Millipore, IPVH08130) at 395mA for 70 minutes at 4oC. The membrane was 
washed twice for 5 minutes with TBST prior to blocking overnight with 10% milk 
solution at 4oC. After washing twice with TBST, the membrane was incubated for 
one hour at room temperature in the appropriate dilution of primary antibody (see 
Table 2.1) in 5% milk solution. Primary antibody was removed by washing the 
membrane four times for 15 minutes each in TBST before incubating for one hour at 
room temperature in the appropriate dilution of secondary antibody (see Table 2.1). 
Secondary antibody was removed by washing the membrane four times for 15 
minutes in TBST. The bands were visualised using SupersignalTM West Pico (Pierce, 
#34080) as described in manufacturer’s instruction and detected by exposing 
(typically 10s – 1 minute) on to Hyperfilm (Amersham, RPN2103) and developed 
using a Konica-Minolta SRX-101A developer. 
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Table 2.1 Antibodies and dilutions used for Western blotting. 
Antibody Dilution Supplier, Catalogue number Secondary Antibody
Cdx2 1:2000 Abcam, ab22586  rabbit-HRP 
Nanog (75x36) 1:3000 Kind gift from Dr. I Chambers  rabbit-HRP 
Oct-4 (C10) 1:2000 Santa Cruz, Sc5279  mouse-HRP 
mouse-HRP 1:2500 Amersham, NA931 N/A 
 rabbit-HRP 1:2500 Amersham, NA934 N/A 
 
2.4.2 Immunohistochemical staining. 
 Embryos were recovered from timed-matings by flushing the uteri/oviduct 
with PB1 + 10%FCS before transferring to PBS.  
 Embryos/cells were washed, twice with PBS, then fixed at room temperature 
for 10 minutes in 4% PFA. After washing twice for 5 minutes in PBST, the cells 
were then blocked and permeabilised at room temperature for 20 minutes in PBST 
containing 3% serum (derived from the same species as the secondary antibody was 
raised in) and 1% BSA (blocking solution). The cells were then incubated with the 
appropriate dilution of primary antibody (see Table 2.2) at 4oC overnight in blocking 
solution. Primary antibody was removed with four washes in PBST for five minutes 
each. The cells were then incubated with secondary antibody (see Table 2.2) at room 
temperature, in the dark for 1 hour in blocking solution. Secondary antibody was 
removed by washing four times for 5 minutes with PBST before staining the cells 




 - 48 -
Table 2.2 Antibodies and dilutions used for immunohistochemical staining. 
Antibody Dilution Supplier, Catalogue number Secondary Antibody
Cdx2 1:80 Abcam, ab22586  rabbit-HRP 
Nanog (75x36) 1:30,000 Kind gift from Dr. I Chambers 
Alexa 488 goat -
rabbit IgG (H+L) 
-Oct-4 (C10) 1:200 Santa Cruz, Sc5279 
Alexa 594 goat -
mouse IgG2b 
Alexa 488 goat 
-rabbit IgG 
1:1000 Invitrogen, A11008 N/A 
Alexa 594 goat -
mouse IgG2b 
1:1000 Invitrogen, A21145 N/A 
 
2.4.3 In-situ Hybridisation of embryos and cells 
 Early stage embryos were isolated as described below, placed on ice and 
washed twice with cold PBS before fixing overnight at 4oC in 4% paraformaldehyde 
in PBS. Embryos were then processed as follows: 
 
2.4.3.1 Pretreatment 
 Washed twice with cold PBT before dehydrating by successive 5 minute 
washes of 25%, 50% and 75% methanol-PBS followed by two washes in 
100% methanol. 
 Rehydrated by successive 5 minute washes with 75%, 50% and 25% 
methanol in PBS. 
 Washed three times with PBT at room temperature. 
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 Washed three times in RIPA (1% Triton X100 in PBS for cells), 30 minutes 
per wash. 
 Post-fixed for 20 minutes in PG-PBT at room temperature with mixing. 
 Washed five times with PBT at room temperature, for 5 minutes each time. 
 
2.4.3.2 Hybridisation 
 Washed for 15 minutes with 1:1 mix of Hybridisation Buffer (HB) and PBT 
at room temperature. 
 Washed once with HB at room temperature. 
 Prehybridised for 5 hours (overnight for cells) at 70oC in HB containing 
100µg/ml tRNA and 100µg/ml sheared denatured herring sperm DNA. 
 Digoxigenin-labelled riboprobe (see below for preparation) denatured by 
heating at 95oC for 10 minutes then placing on ice. NB. Anti-sense riboprobe 
used as a control. 
 Hybridised in HB containing 100µg/ml tRNA and denatured DNA overnight 
at 70oC in a chamber humidified with 50% formamide. 
 Washed for 10 minutes in HB at 70oC. 
 Washed twice for 5 minutes with SSC-FT at room temperature. 
 Washed three times for 30 minutes with SSC-FT at 65oC. 
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2.4.3.3 Antibody binding 
 Blocked in 10% heat-inactivated sheep serum in TBST for 1 hour. 
 Block replaced with 1:2000 dilution of freshly preadsorbed anti-digoxigenin 
Fab-alkaline phosphatase conjugate (Boehringer Mannheim) in TBST with 
1% heat-inactivated sheep serum and incubated overnight at 4oC. 
 
2.4.3.4 Washing and colour development 
 Antibody conjugate removed and washed with TBST at room temperature 
three times for 5 minutes followed by four times for 30 minutes. 
 Washed three times for 10 minutes with APB. 
 Stained in a solution of 4.5µl/ml NBT and 3.5µl/ml BCIP in APB in dark 
until colour develops (NB. embryos transferred to glass dish prior to 
staining). 
 Reaction stopped by washing three times in 1mM EDTA in PBS. 
 
2.4.3.5 Riboprobe synthesis 
 The following were combined in an eppendorf tube – 
  1-3ug linearised template DNA 
  10l 5x dNTP mix, containing 11-digoxigenenin-UTP 
  5l 10x transcription buffer 
  50 units RNase inhibitor 
  50 units appropriate phage RNA polymerase 
  to 50l final volume with DEPC-treated water. 
 
 The reaction was incubated at 37oC for two hours then added 20 units of 
RNase-free DNase and incubated at 37oC for 15 minutes. The reaction was stopped 
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by the addition of EDTA to a final concentration of 25mM. The DNA was 
precipitated with 1/10th volume 4M LiCl and three volumes of absolute ethanol and 
cooling overnight at -20oC. The DNA was pelleted by centrifugation at 16,000g for 
15 minutes. The pellet was washed twice, carefully, with 70% ethanol, then air-dried 
and resuspended in 100l DEPC-treated water. Riboprobe size and quality was 
confirmed by agarose gel electrophoresis. 
 
Table 2.3 Riboprobes for in situ hybridisation. 
Riboprobe Vector Polymerase
Nanog sense pPyCAG-rat Nanog-IP T7 
Nanog anti-sense pPyCAG-rat Nanog-IP SP6 
Oct4 sense pPyCAG-rat Oct4-IP SP6 




 Typically one tenth of cDNA sample was amplified in a 50µl reaction on a 
PTC-200 thermocycler (MJ Research) using 2.5U GoTaq Flexi DNA Polymerase 
(Promega Corporation, #M8305) under the following conditions; 94oC 2 minutes, 
followed by 30 cycles of 94oC 20 seconds, 50oC 20 seconds and 72oC 1 minute, with 
a final extension at 72oC for 5 minutes. The primer sequences used and the product 
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Table 2.4 Oligoncleotides used for RT-PCR analysis. 
Rat mRNA Sequence (5’ to 3’) Product size 
For - CACTGGCATTGTGATGGACT 
-actin 
Rev - ACGGATGTCAACGTCACACT 
427 
For - AACTGCGAGTGGGTCTGGAAG 
Brachyury 
Rev - TGGGTCTCGGGAAAGCAGTG 
451 
For - CCGAATACCACGCACACCATC 
Cdx2 
Rev - CTTTCCTTGGCTCTGCGGTTC 
394 
For -  CCTCAGTGGTCTTCCCCTACC 
c-Myc 
Rev - GCTGTGTGGAGGTTTGCTGTG 
284 
For - CGAGCGGTGTGGGTAAAAGTG 
Eras 
Rev - GGTGTCGGGTCTTCTTGCTTG 
501 
For -  TGTGCGGGGACATTGCTTCTG 
Errβ 
Rev - TCCCGATCTGCCAAGTCACAG 
436 
For -  CGGGGTGTGGTGAGCATCTTC 
FGF4 
Rev - CCTTCTTGGTCCGCCCGTTC 
202 
For -  TCATCACGACGGCTTGGACTG 
GATA6 
Rev - GCCAGAGCACACCAAGAATCC 
467 
For - ATACACCTGCACAGCGTACAG 
Kdr 
Rev - TCCCGCATCTCTTTCACTCAC 
271 
For - CAGTCGCAAGTCCCCTCTCTC 
Klf4 
Rev - CCTGTCGCACTTCTGGCACTG 
321 
For -  GCCCTGAGAAGAAAGAAGAG 
Nanog 
Rev - CTGACTGCCCCATACTGGAA 
356 
For -  AGAGAAGCGCTGGAACAGAG 
Nestin 
Rev - AGGTGTCTGCAACCGAGAGT 
234 
For -  GGGATGGCATACTGTGGAC 
Oct-4 
Rev - CTTCCTCCACCCACTTCTC 
412 
For -  GAGACTGGCTCCATCAGACC 
Pax6 
Rev – CTAGCCAGGTTGCGAAGAAC 
212 
   
 - 53 -
For -  TTCTTGCCAGGTTCTGGAAGC 
Rex1 
Rev - TTTCCCACACTCTGCACACAC 
277 
For -  GGCGGCAACCAGAAGAACAG 
Sox2 
Rev – GTTGCTCCAGCCGTTCATGTG 
414 
For - AGGAGAGGTGGTGGCGAGTAG 
Sox17 
Rev - GTTGGGATGGTCCTGCATGTG 
268 
For – TCCTACAACCAGAAACACTAG 
Stella 
Rev – GTGCAGAGACATCTGAATGG 
304 
 






2.4.5 Southern Blotting 
 5µg of genomic DNA were digested with 40U of the appropriate restriction 
enzyme for 3-4 hours at the correct temperature. A further 40U of enzyme was then 
added and incubated overnight. The digested DNA was run overnight at 20V on a 
0.7% agarose gel. The gel was stained with Ethidium bromide and photographed 
under short wave UV fluorescence to nick the DNA. The gel was then washed twice 
in denaturing solution for 20 minutes each with gentle agitation. A brief rinse in 
distilled water was carried out prior to two washes in neutralising solution for 20 
minutes each. The gel was then blotted overnight onto charged nylon membrane 
(Millipore, INYC00010) in 20xSSC. Following transfer, the membrane was washed 
in 2xSSC and the DNA fixed by baking at 120oC for 2 hours. The membrane was 
washed briefly in 2xSSC prior to hybridization with radiolabelled probes.  
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2.4.5.1 Radiolabelling of DNA probe 
 25ng of DNA in TE buffer was labeled with RediprimeTM II Random Prime 
Labelling System (GE Healthcare, #1633) following the manufacturer’s protocol, 
using 50µCi RedivueTM [32P] d-CTP (GE Healthcare, #AA0005). Unincorporated 
nucleotides were removed by passing the reaction through a ProbeQuantTM G-50 
micro column (GE Healthcare, #27-5335-01) according to manufacturer’s 
instructions. The probe was then denatured by boiling for 5 minutes and cooled 
quickly on ice for 5 minutes before adding to the hybridization mixture. 
 
2.4.5.2 Hybridisation of membranes with radioactive probes 
 The membrane was washed briefly in 2xSSC, then pre-hybridised for 3 hours 
at 65oC in 25ml of hybridization mix containing 1.25ml of pre-boiled 0.2M Tris 
pH8.0 and 10mg/ml Salmon sperm DNA in 0.4M NaOH (1:1). The denatured, 
radiolabelled probe was diluted in 10ml of hybridization mix containing Tris and 
Salmon sperm as before, then added to the membrane and incubated for 24 hours at 
65oC. The following day, the hybridization mix was removed and the membrane 
washed briefly with 2xSSC followed by two, 10 minute washes with 
2xSSC/0.1%SDS and one, 5 minute wash with 0.1xSSC/0.1%SDS (wash solutions 
were pre-heated to 65oC). The blot was then exposed for 3 days on Biomax XAR 
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2.4.6 Microsatellite genotyping 
 Fluorescent-tagged oligonucleotides (Applied Biosystems) were used to 
amplify the rat microsatellite regions D1Rat122, D3Rat17 and D2Rat250. Genomic 
DNA was extracted from tail, ear and blood biopsies. PCR reactions were amplified 
in a PTC-200 thermocycler (MJ Research) using Taq DNA Polymerase (Invitrogen) 
under the following conditions; 95oC 2 minutes, followed by 35 cycles of 94oC for 
30 seconds, 58oC or 66oC for 45 seconds and 72oC for 45 seconds, with a final 
extension at 72oC for 10 minutes. Annealing temperatures were 62oC, 58oC and 66oC 
for D1Rat122, D3Rat17 and D2Rat250 respectively. PCR products were diluted 1 in 
100 in sterile, distilled water. 2μl of this was diluted in 18μl Hi-Di Formamide 
(Applied Biosystems) containing LIZ-500 internal size standard (Applied 
Biosystems). The resulting products were detected on an ABI capillary 3730 DNA 
analyzer and visualised on a 4% agarose gel. D1Rat122 alleles are 230bp and 255bp 
for DA and Fischer rat strains respectively, D3Rat17 alleles are 140bp and 154bp for 
DA and SD strains respectively, and D2Rat250 alleles are 156bp, 168bp and 190bp 
for SD, DA and Fischer rat strains respectively. 
 
Table 2.5  Oligoncleotide sequences for microsatellite analysis. 
Microsatellite 
region 
Direction Oligonucleotide sequence Fluorescent tag 
Forward CTGCTCCACCTGCCTGTATT 6-FAM (blue) 
D1Rat122 
Reverse TCCCTTTGCAATAGACAATGG  
Forward TCATTTTCCTTCCTCTCTCTCA VIC (green) 
D3Rat17 
Reverse AAGACAAAATGCTGGAGGGA  
Forward GTCCCTCTCCTGTCCCTCTC PET (red) 
D2Rat250 
Reverse GAAGTCTGAACGCTCATGCA  
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2.4.7 Genomic PCR 
 100-200ng of genomic DNA was amplified using oligonucleotides designed 
against the rat Sry gene or GFP transgene. Sry primers give no product from mouse 
genomic DNA. IL2 oligonucleotides were included in each reaction as an internal 
control. The PCR was performed in a PTC-200 thermocycler (MJ Research). For Sry 
PCR, GoTaq Flexi DNA Polymerase (Promega) was used along with the following 
conditions; 95oC for 2 minutes, followed by 35 cycles of 94oC for 30 seconds, 50oC 
for 1 minute and 72oC for 1 minute, with a final extension at 72oC for 10 minutes. 
For GFP PCR, Taq DNA Polymerase (Invitrogen) was used along with the following 
conditions; 95oC for 2 minutes, followed by 35 cycles of 94oC for 30 seconds, 55oC 
for 30 seconds and 72oC for 30 seconds, with a final extension at 72oC for 10 
minutes. PCR products were visualised with ethidium bromide on a 2% agarose gel. 
The IL2 PCR product is 324bp, the Sry product is 104bp and the GFP product is 
173bp. 
 
Table 2.6  Oligoncleotide sequences for genomic PCR. 
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2.4.8 DNA sequencing 
 1µg of miniprepped vector DNA was mixed with 3.2pmoles of sequencing 
primer in a 6µl volume. Sequencing was carried out by University of Edinburgh, 
School of Biological Sciences Sequencing Service using BigDye Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems, #4337445) and analysed on a 3730 
DNA Analyser (Applied Biosystems). 
 
2.5 Vibratome sectioning 
 Fluorescent embryos were embedded in a 1:1 mixture containing 20% gelatin 
and 20% albumin in PBS then fixed overnight at 4oC in 4% Paraformaldehyde. The 
gelatin blocks were then embedded in a ‘setting solution’ with 10% Glutaraldehyde 
overnight at 4oC. Transverse sections were cut in a Series 1000 Vibratome at 100µm 
and then treated with PBST for 10 minutes prior to mounting under coverslips in 
Vectashield (Vector Laboratories) containing DAPI nuclear fluorescent stain. 
Confocal microscopy was performed on the sections within 24 hours of sectioning. 
The ‘setting solution’ is prepared by combining 450ml PBS with 2.2g gelatin, 70g 
BSA and 90g sucrose. The gelatin is added to the PBS, heated to dissolve then 
allowed to cool. The BSA is then added, allowing a thin layer of albumin to form on 
the surface that dissolves very slowly. Once dissolved, the sucrose is added and the 
final solution aliquoted and stored at -20oC. 
 
2.6 Animals 
 Rats were housed and bred within the University of Edinburgh according to 
the Animals (Scientific Procedures) Act (UK) 1986. They were maintained on a 
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cycle of 12 hours dark, 12 hours light, with the midpoint of the dark cycle at 0100. 
Litters from natural matings were left with parents until 4 weeks of age, at which 
point they are weaned by separating the offspring from their parents. At weaning the 
animals were sexed and tail tips, ear punches and blood were taken for genotyping. 
Breedings, tissue biopsies, bleeding and maintenance of animal stocks were 
performed by the Biomedical Facility staff at the ISCR. 
 
2.7 Cell culture 
2.7.1 Cell attachment substrates 
2.7.1.1 DIA-M feeder layer 
 The DIA-M feeder cells are C3H/10T1/2 mouse fibroblasts that have been 
stably transfected with an expression vector for the matrix-associated form of LIF 
(Rathjen et al., 1990). Cells were maintained in GMEM + 10% FCS, without LIF and 
grown to confluency in a 75cm2 flask then gamma-irradiated and plated into gelatin-
coated (0.1%) 4-well dishes (2cm2/well) at a density of 1.5 x 104 cells/well. 
 
2.7.1.2 Gelatin Coating 
 Wells were coated in 0.1% gelatin for five minutes at room temperature. The 
gelatin was aspirated and wells allowed to dry in tissue culture hood for 5 minutes. 
 
2.7.1.3 Laminin Coating 
 Wells were coated in 10µg/ml Laminin (Sigma, L1010) overnight at 37oC. 
Laminin was aspirated and wells washed three times with PBS before plating cells. 
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2.7.2 Immunosurgery 
 After removing the zona pellucida with acid Tyrode’s solution, blastocysts 
were incubated for 1 hour at 37oC (no CO2) in PB1 (filter sterilised) containing rabbit 
anti-rat serum antibody (Sigma, R5256) at a dilution of 4:1. The blastocysts were 
then rinsed three times in successive drops of PB1 (filter sterilised) containing 10% 
FCS before transferring to PB1 (filter sterilised) containing rat complement serum 
(Sigma, S3394) at a dilution of 4:1. They were monitored frequently until the 
trophectoderm had lysed, then transferred to GMEM + 10% FCS for 30-60 minutes. 
 
2.7.3 Derivation and culture of rat ExS cells 
 Rat blastocysts were collected at 4.5d.p.c and the zona pellucida removed 
with acid Tyrode’s solution (Sigma, T1788). Immunosurgery was then carried out to 
remove the trophectoderm and isolate the ICM. The resulting ICMs were plated and 
cultured in Rat Cell Growth Medium (RCGM) on a layer of gamma-irradiated DIA-
M cells. 80µg MatrigelTM (BD Biosciences, 354234) was also added to the culture. 
Cells were allowed to attach and outgrow for 4 days, then mechanically 
disaggregated into small clumps using a drawn-out Pasteur and moved to fresh DIA-
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2.7.4 Passaging rat ExS cells 
 Colonies of ExS cells were passaged in one of three ways described below: 
 
2.7.4.1 Mouth pipetting (without trypsin). 
 This technique was used when there were only a small number of colonies 
(<10). Colonies were mechanically disaggregated into smaller pieces under a low-
power microscope, using a drawn-out Pasteur and fine gauge syringe needle. 
 
2.7.4.2 Mouth pipetting (with trypsin). 
 This technique was used when there were only 10 to 20 colonies growing in 
culture. Colonies were removed from the DIA-M feeder layer using a mouth pipette 
and transferred sequentially to a well containing PBS, then a well containing Trypsin 
and incubated 37oC 3-5 minutes. Finally, colonies were dispersed to a near-single 
cell suspension into a well containing RCGM using a fine Pasteur, then seeded into a 
fresh well. 
 
2.7.4.3 Trypsinising colonies in situ. 
 This technique was used when there were a large number of colonies growing 
in culture (>20). Cells were washed three times with PBS then 200µl Trypsin added 
and incubated 37oC for 3-5 minutes. Colonies were dispersed to a near-single cell 
suspension by pipetting, then transferred to a universal containing 5-10ml GMEM + 
10% FCS and centrifuged at 300g for 3 minutes. The supernatant was carefully 
aspirated and the cell pellet resuspended in 200µl RCGM and plated at the 
appropriate dilution(s). 
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2.7.5 Freezing and thawing rat ExS cells 
 Cells were washed three times with PBS then 200µl Trypsin added and 
incubated 37oC for 5 minutes. The cells were dispersed to near-single cell suspension 
by pipetting, transferred to a universal containing 5ml GMEM + 10% FCS and 
centrifuged 300g for 3 minutes. The supernatant was aspirated and the cell pellet 
resuspended in 1ml RCGM and this divided equally into two cryovials. An equal 
volume (500µl) of 2x Freezing mix was added to each, mixed carefully, then 
transferred to -80oC immediately and to LN2
 the next day. 
 Cells were thawed into a universal tube containing 20ml pre-warmed (37oC) 
GMEM + 10% FCS by transferring warm medium back and forth between universal 
tube and vial until all the contents of the vial had been transferred to the universal. 
The cells were pelleted by centrifugation at 300g for 3 minutes. The supernatant was 
aspirated and the pellet resuspended in 200µl RCGM and plated equally over two 
wells of a 4-well plate in a volume of 500µl/well. The cells were allowed to adhere 
overnight before adding Matrigel the next day. 
 
2.7.6 Derivation and culture of rat ES cells. 
 Rat ES cells were originally derived by Mia Buehr. Rat blastocysts were 
collected at 4.5d.p.c and the zona pellucida removed with acid Tyrode’s solution 
(Sigma, T1788). Immunosurgery was carried out to remove the trophectoderm and 
isolate the ICM. Blastocysts were incubated for 1 hour at 37oC (no CO2) in PB1 
(filter sterilised) containing rabbit anti-rat serum antibody (Sigma, R5256) at a 
dilution of 4:1. The blastocysts were then rinsed three times in successive drops of 
PB1 (filter sterilised) containing 10% FCS before transferring to PB1 (filter 
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sterilised) containing rat complement serum (Sigma, S3394) at a dilution of 4:1. 
They were monitored frequently until the trophectoderm had lysed, then transferred 
to GMEM + 10% FCS for 30-60 minutes. The resulting ICMs were plated and 
cultured in 3i medium on a layer of gamma-irradiated DIA-M cells. Cells were 
allowed to attach and outgrow for between five and seven days, then mechanically 
disaggregated into small clumps using a drawn-out Pasteur and moved to fresh DIA-
M feeders in 3i medium. 
 
2.7.7 Passaging rat ES cells 
2.7.7.1 Mouth pipetting 
 Colonies were disaggregated under a low power microscope by mouth 
pipetting using a drawn-out Pastuer pipette. 
 
2.7.7.2 Dispersing colonies to single cells.  
 Cells were washed with 500µl PBS then 200µl Accutase (Sigma, A6964) 
added and incubated 37oC for 2-3 minutes. Colonies were dispersed to single cell by 
pipetting and transferred to a universal containing 5ml GMEM + 10% FCS. The cells 
were pelleted at 300g for 3 minutes then the supernatant carefully aspirated. The 
pellet was finally resuspended in an appropriate volume of 3i medium for plating or 
freezing. 
 
2.7.8 Freezing and thawing rats ES cells. 
 Cells were dispersed to a single-cell suspension with Accutase (Sigma, 
A6964) then pelleted in GMEM + 10% FCS at 300g for 3 minutes. The pellet was 
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resuspend in 3i medium to give a final volume of 500µl/vial. 500µl cell suspension 
was transferred to a cryovial then 500µl 2xFreezing mix 
(N2B27+20%DMSO+20%FCS) added and mixed carefully. 
 Cells were thawed into a universal tube containing 20ml pre-warmed (37oC) 
GMEM + 10% FCS by transferring warm medium back and forth between universal 
tube and vial until all the contents of the vial had been transferred to the universal 
tube. The cells were pelleted by centrifugation at 300g for 3 minutes. The 
supernatant was aspirated and the pellet resuspended in 200µl 3i medium. The cell 
suspension was divided over two wells of a 4-well plate in a volume of 500µl/well. 
 
2.7.9 Teratoma formation 
 Approximately 200-400 cells were injected under the kidney capsule of SCID 
mice (BALB/c JHan Hsd-Prkdc scid). Tumours were collected at various times, and 
their weight determined by weighing both tumour and kidney, then subtracting the 
weight of the contralateral uninjected kidney. Tumours were embedded in paraffin 
wax, sectioned, and stained with Masson’s trichrome by Ron Wilkie. 
 
2.7.10 Blastocyst injections and chimaera production 
 Blastocyst injections were performed, by Jan Ure or Renee McLay, based on 
protocols previously described (Bradley et al., 1984). Rat ES cells derived from DA 
and F344 rat strains were injected into the blastocoel cavity of F344 and DA 
blastocysts respectively. Blastocysts were usually cultured for 2-3 hours in KSOMAA 
(Biggers et al., 2000) to allow the blastocoel cavity to become fully expanded. Rat 
ES cells were prepared for injection by transferring several large colonies from the 
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feeder layer to a well containing 400µl Accutase (Sigma, A6964), incubating at 37oC 
for 3 minutes before pipetting to single-cell suspension. The cell suspension was 
spun in 5ml of GMEM + 10% FCS at 300g for 3 minutes in an Eppendorph 5702 
centrifuge and the resultant pellet resuspended in an appropriate volume of M2 
(Sigma-Aldrich, #M7167) medium. 10-15 cells were injected into each blastocyst 
and approximately 8 injected blastocysts were transferred to the uterine horn of a 
pseudo pregnant recipient rat. Chimeric pups were initially identified by coat colour 
chimaerism and confirmed by microsatellite analysis. 
 
2.7.11  Transfection of cells 
2.7.11.1 Lipofection of rat ExS cells 
 Colonies were dissociated with Trypsin and the cells pelleted in GMEM + 
10% FCS at 300g for 3 minutes. The pellet was then resuspended in RCGM and 
plated in a final volume of 400µl. Stably-expressing cell lines were generated by 
lipofection using Lipofectamine™ 2000 (Invitrogen, 11668-027) as detailed in the 
manufacturer’s instructions. A mixture of 1µg ScaI-linearised expression vector 
DNA and 1µl Lipofectamine™ 2000 was added to the culture and incubated 
overnight. The reagents were removed after 18 hours and replaced with RCGM 
culture medium. Stable transfectants were selected in appropriate selection (1µg/ml 
Puromycin (Sigma, PA8833) and/or 20µg/ml Zeocin (Invitrogen, R250-01)) applied 
48 hours after transfection and subsequently maintained in selection. Polyclonal lines 
were obtained by pooling several resistant colonies. 
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2.7.11.2 Lipofection of rat ES cells 
 Colonies were dissociated with Accutase (Sigma, A6964), pelleted in GMEM 
+ 10% FCS then resuspended in 3i culture medium containing 10% FCS and plated 
in a final volume of 400l. The cells were transfected using Lipofectamine™ LTX 
(Invitrogen, 15338-100) according to manufacturer’s instructions. A mixture of 
0.25g ScaI-linearised pPYCAGgfpIP vector DNA, 0.25l PLUS reagent 
(Invitrogen, 11514-015) and 0.625l Lipofectamine™ LTX was added to the culture 
then incubated overnight. The reagents were removed after 18 hours and replaced 
with fresh serum-free 3i culture medium. Stable transfectants were selected in 
0.5g/ml Puromycin applied 48 hours after transfection and subsequently maintained 




 1x106 2i rat ES cells were electroporated in PBS or N2B27+10% FCS  
with 5, 20 or 50µg ScaI linearised pPyCAGegfpIP vector using the Bio-Rad  
Genepulser apparatus (0.8kV, 3µF). 6x105 electroporated cells were plated into a  
10cm2 well containing 2i medium + 5% FCS. The following day the medium was 
replaced with serum-free 2i. 1µg/ml puromycin selection was added 72h post-  
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2.7.12   Lentiviral shRNA infection 
2.7.12.1 Construction of pSicoR Cdx2 shRNA lentiviral vectors 
 Cdx2 shRNA oligonucleotides were designed from rat Cdx2 cDNA sequence 
using pSicoOligomaker 1.5 (http://web.mit.edu/ccr/labs/jacks/protocols/pSico.html). 
The oligonucleotides were produced by Integrated DNA Technologies (IDT®) with 
HpaI and XhoI overhangs incorporated into the sequence (Table 2.3). 100M each, 
of sense and antisense oligonucleotides, were annealed in a 100l reaction with 25l 
2x annealing buffer using the following cycling conditions; 94oC for 4 minutes, then 
70oC for 10 minutes, -1oC/cycle for a further 65 cycles. 1x10-1 pmoles of annealed 
oligonucleotides were ligated into 1.2x10-2pmoles HpaI/XhoI digested and gel-
purified pSicoR vector (kindly supplied by Professor Tyler Jacks, Massachusetts 
Institute of Technology, http://web.mit.edu/ccr/labs/jacks/protocols/pSico.html) in a 
20l reaction using 400U T4 DNA Ligase (NEB, M0202S). 20l of the ligation 
reaction was transformed into 50l One Shot Stbl3 competent cells (Invitrogen, 
C7373-03). A selection of the resultant colonies were grown in LB containing 
50g/ml final Ampicillin and DNA purified using the Endofree Plasmid Maxi Kit 
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1808 sense 5’ 
TGT ATG TCT GTG TCG TAA ATT TCA AGA GAA TTT ACG 
ACA CAG ACA TAC TTT TTT C 
1808 antisense 5’ 
TCG AGA AAA AAG TAT GTC TGT GTC GTA AAT TCT CTT 
GAA ATT TAC GAC ACA GAC ATA CA 
725 sense 5’ 
TGA AGG AAT TTC ACT ATA GTT TCA AGA GAA CTA TAG 
TGA AAT TCC TTC TTT TTT C 
725 antisense 5’ 
TCG AGA AAA AAG AAG GAA TTT CAC TAT AGT TCT CTT 
GAA ACT ATA GTG AAA TTC CTT CA 
2006 sense 5’ 
TGG AGG GGG ATA TCT GAA CAT TCA AGA GAT GTT CAG 
ATA TCC CCC TCC TTT TTT C 
2006 antisense 5’ 
TCG AGA AAA AAG GAG GGG GAT ATC TGA ACA TCT CTT 
GAA TGT TCA GAT ATC CCC CTC CA 
1808 mutated sense 5’ 
TGT CCG TCT GTA TCG TCA ATT TCA AGA GAA TTG ACG 
ATA CAG ACG GAC TTT TTT C 
1808 mutated antisense 5’ 
TCG AGA AAA AAG TCC GTC TGT ATC GTC AAT TCT CTT 
GAA ATT GAC GAT ACA GAC GGA CA 
 
2.7.12.2  Lentiviral stock production 
 Lentiviral stocks were produced using 293FT cells. These cells were derived 
from the 293-F cell line, which is a fast-growing variant of the 293 cell line. The 293 
cell line was originally established from primary embryonal human kidney, 
transformed with sheared human adenovirus type 5 DNA (Graham, Smiley et al. 
1977; Harrison, Graham et al. 1977). The E1A adenovirus gene is expressed in these 
cells and participates in transactivation of some viral promoters, allowing these cells 
to produce very high levels of protein. The 293FT cell line stably expresses the SV40 
large T antigen from the pCMVSPORT6TAg.neo vector. Expression of the SV40 
large T antigen is controlled by the human cytomegalovirus (CMV) promoter and is 
high-level and constitutive. 
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 3μg of pSicoR lentiviral expression vector DNA and 9μg of the ViraPower™ 
Packaging Mix (Invitrogen, K4975-00) were diluted in 1.5 ml of Opti-MEM® I 
Medium (Invitrogen, 31985-062) without serum and gently mixed. In a separate tube 
36μl Lipofectamine™ 2000 was diluted in 1.5ml of Opti-MEM® I Medium without 
serum and gently mixed then incubated for 5 minutes at room temperature. After the 
5 minute incubation, the diluted DNA was combined with the diluted 
Lipofectamine™ 2000 (Invitrogen, 11668-027), gently mixed then incubated for 20 
minutes at room temperature to allow the DNA/Lipofectamine™ 2000 complexes to 
form. While DNA-lipid complexes were forming, the 293FT cells were washed twice 
with PBS, trypsinised, spun for 3 minutes at 300g in DMEM. The pelleted cells were 
then resuspended in DMEM to a density of 1.2x106/ml. After allowing the 
DNA/Lipofectamine™ 2000 complexes to form, they were added to a 10cm tissue 
culture plate containing 5ml of DMEM. Finally, 5ml (6 x 106 total cells) of the 
293FT cell suspension was added to the dish containing the DNA/Lipofectamine™ 
2000 complexes and mixed gently by rocking the dish back and forth then incubated 
overnight at 37°C in a CO2 incubator. The next day, the medium containing the 
DNA-Lipofectamine™ 2000 complexes was removed and replaced with DMEM 
containing 1mM sodium pyruvate (Invitrogen, 11360-039). 72 hours post-
transfection, the virus-containing supernatant was harvested by removing medium to 
a 15ml sterile, capped, conical tube and centrifuging at 1400g for 15 minutes at 4°C 
to pellet cell debris. The supernatant was then centrifuged in an SW41 Beckman 
rotor at 107,000g for 90 minutes. The resultant supernatant was discarded and any 
excess removed by inverting the tubes on a paper towel for 10 minutes. 40l cold 
PBS was added to the pellet and stored overnight at 4°C. The next day the PBS, now 
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containing the viral stock, was washed gently around the bottom of the tube by 
pipetting and transferred to a cryovial then stored at -80°C. 
 
2.7.12.3  Titrating Lentiviral stock 
4x105 293FT cells/well were plated in a 6-well plate 12-24 hours prior to titering. A 
10-fold serial-dilution of virus was prepared in 1.5ml DMEM containing 8g/ml 
Polybrene (Hexadimethrine bromide, Sigma, H9268) to give 5l, 0.5l and 0.05l 
virus/well. An additional negative control was set up using DMEM/Polybrene 
without virus. The cells were then incubated at 37°C overnight and the lentiviral-
containing medium removed the next day and replaced with fresh DMEM. 72 hours 
after infection the cells were trypsinised, centrifuged in DMEM at 300g for 3 
minutes, and resuspend in 500l cold PBS containing 2% FCS for FACS analysis for 
GFP expression, and the percentage of GFP positive cells recorded. A well with 
0.1% and 10% of cells expressing GFP was used to determine the titer. 
Sample calculation  
Assuming 1% infection from the well with 0.0ll of virus: 
0.01 (percentage of cells that are EGFP positive) x 4 x 105 = 4 x 103 positive cells. 
4 x 103 x 100 (dilution factor) = 4 x 105 viral particles/l. 
 
2.7.12.4  Lentiviral infection of rat ExS cells 
 Cells were trypsinised and plated 24 hours prior to infection. Lentiviral stock 
was added to the cells in a final volume of 500l RCGM containing 8g/ml 
Polybrene (Hexadimethrine bromide, Sigma, H9268). The lentiviral-containing 
medium was removed the next day and replaced with fresh RCGM.  
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2.7.13 LIF-independent self renewal assay 
 The LIF-independent self-renewal assay was facilitated by the production of 
lifr knockout (LRK1) mouse ES cells (Chambers et al., 2003). LRK1 cells eliminate 
the background of undifferentiated cells that occurs in the absence of exogenous LIF 
due to the production of LIF by differentiated cells. These cells can be maintained in 
the absence of LIF by activation of gp130 using interleukin-6 and soluble 
interleukin-6 receptor (IL6/sIL6R).  1x106 LRK1 cells were transfected with 3µg 
circular vector DNA using 3µl LipofectamineTM 2000 (Invitrogen, 11668-027) as 
according to manufacturer’s instructions. The reaction was allowed to proceed for 24 
hours. Cells were then trypsinised and plated at 2x105 and 5x104 in duplicate into 
9cm2 gelatinised dishes. 1µg/ml Puromycin selection was added and IL-6/sIL6R 
added to one of the two dishes. Cells were fed every second day and then stained for 
Alkaline Phosphatase (Sigma, 86R-1KT) after 14 days. 
 
2.7.14 Alkaline phosphatase staining 
 Cells were washed in-situ with 5ml of PBS and fixed with 3ml of Fix solution 
(65ml Acteone, 25ml Citrate solution, 8ml 37% formaldehyde) for two minutes. The 
cells were then washed with 5ml distilled water before staining with 4.5ml Staining 
solution for fifteen minutes, at room temperature, in the dark. Staining solution was 
prepared by mixing 1ml Sodium Nitrite with 1ml FRV-alkaline solution and 
incubating at room temperature for two minutes before adding to 45ml distilled water 
and then adding 1ml Naphthol AS-BI alkaline solution (all reagents supplied with 
kit, Sigma, 86R-1KT). After staining, the cells were washed once with distilled 
water, air-dried and the colonies scored. 
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Chapter 3 
Nanog expression pattern in rat ExS cells and the rat embryo 
 
3.1 Introduction 
 Whilst the derivation of genuine rat ES cells has so far proved elusive, ES-
like cells have been derived by several laboratories from a variety of species, 
including rat (Buehr et al., 2003; Iannaccone et al., 1994; Li et al., 2003; Ruhnke et 
al., 2003; Saito et al., 2002; Vassilieva et al., 2000; Verma et al., 2007; Yadav et al., 
2005). 
 Rat ES-like cells have been derived in this laboratory from the ICM of E4.5 
blastocysts and subsequently maintained in vitro (Buehr et al., 2003). These have 
been termed ExS cells due to their extra-embryonic identity. The cells are maintained 
on a feeder layer of mitotically-inactivated mouse C3H 10T1/2 fibroblasts which 
have been modified to express the matrix-associated form of LIF (DIA-M) in the 
presence of FCS, LIF and MatrigelTM. Their morphology is similar to mouse ES cells 
grown on feeders (Figure 3.1A & B). However, although these cells are similar to 
mouse ES cells, in that they self-renew in vitro, stain positive for alkaline 
phosphatase and express SSEA-1, they fail to express the key functional ES cell 
transcription factor Oct4 and fail to generate chimaeras upon blastocyst injection 
(Buehr et al., 2003). 
 Loss of Oct4 expression in mouse ES cells results in loss of pluripotency and 
differentiation into trophectoderm (Nichols et al., 1998; Niwa et al., 2000). Although 
the expression pattern of Oct4 in the rat embryo is equivalent to that  











of mouse (Buehr et al., 2003), Oct4 is downregulated in rat ICM outgrowths within 
the first few days during derivation. 
 Nanog has been demonstrated to maintain mouse ES cell self-renewal in 
parallel with STAT3 activation via LIF-stimulation of gp130 (Chambers et al., 
2003). In the absence of Nanog, mouse ES cells become committed to differentiate 
and pluripotency is compromised (Chambers et al., 2003; Mitsui et al., 2003). In 
vivo, Nanog expression is first observed within the central compartment of the 
compacted mouse morula then later restricted to the ICM and epiblast of the 
blastocyst. At implantation Nanog is downregulated, only to reappear as punctuate 
staining in E11.5 genital ridges, indicative of primordial germ cells. Although 
Nanog-/- embryos form an overtly normal blastocyst, by E5.5 the epiblast is indistinct 
and the embryo is composed mainly of disorganized extra-embryonic tissue. 
Furthermore, when the ICM of Nanog-/- blastocysts are cultured ex vivo, they fail to 
remain undifferentiated, but rather differentiate into parietal endoderm-like cells. 
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 Although the expression pattern of Oct4 in the rat embryo is known, the 
expression pattern of Nanog in ExS cells and the early rat embryo remains to be 
determined. Subtle differences in the timing of Nanog expression during early 
development may indicate a more appropriate embryonic stage suitable for 
derivation. Therefore, the aim of the work described in this Chapter was to determine 
whether ExS cells express Nanog and to investigate the temporal and spatial 
expression pattern of Nanog in the rat embryo. 
 
3.2 Nanog expression 
 Within the first few days during rat ExS cell derivation, Oct4 expression is 
quickly down-regulated such that it cannot be detected by RT-PCR (Buehr et al., 
2003). Likewise, rat ExS cells fail to express Nanog (Figure 3.2A). 
 In order to determine if Nanog is actually expressed in the ICM prior to 
derivation, the rat Nanog transcript was isolated from E4.5 rat embryos by PCR 
using oligonucleotides designed to the predicted rat Nanog mRNA sequence 
XM_575662 (Figure 3.3). This transcript would also be utilised in an expression 
vector for investigation into genetic manipulation of rat ExS cells (see 3.3 and 
chapter 4). The restriction enzyme sites XhoI and NotI were incorporated into the 5’ 
ends of the sequences of the oligonucleotides to facilitate subsequent cloning. The 
Kozak concensus sequence was also incorporated into the 5’ end of the sequence of 
one oligonucleotide. The Kozak sequence is recognized as the translational start site 
by the ribosome and is required to initiate efficient translation (Kozak, 1987). The 
amplified cDNA was cloned into the TOPO pCRII vector (Figure 3.4A) and the 
sequence integrity confirmed. This suggested that Nanog is  















indeed expressed in rat blastocysts. To confirm this and to determine the spatial 
expression pattern of Nanog in rat blastocysts, in situ hybridisation was performed on 
E3.5/4.5 rat embryos using a rat Nanog riboprobe produced from the TOPO pCRII 
clone, as detailed in Chapter 2. It can be seen that the Nanog expression pattern in rat 
is similar to that in mouse at the equivalent stage of development (Figure 3.2B). 
Expression is restricted to the ICM and absent from the trophectoderm. In two cases, 
where the blastocyst cavity has yet to form, expression is confined to the central 
region of the morula, the region which gives rise to the ICM, and absent from the 
outer cells. 
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3.3 Cloning of rat Nanog into expression vector. 
 The rat Nanog cDNA was successfully cloned, as discussed in Section 3.2, 
and an expression vector was constructed using this. The XhoI/NotI rat Nanog cDNA 
fragment was excised from the TOPO pCRII clone (Figure 3.4A) and used to replace 
the XhoI/NotI stuffer fragment in the pPyCAG-IP vector (Figure 3.4B) creating a 
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 3.4 Functional assay of rat Nanog expression vector. 
 The ability of Nanog to mediate LIF-independent self-renewal was utilized in 
a functional assay to test the rat Nanog expression vector. However, due to the 
production of LIF by differentiated cells, a background population of 
undifferentiated ES cells persist, even in the absence of LIF (Rathjen et al., 1990). 
LIF acts via the LIFR/gp130 complex. In order to remove the undifferentiated 
background in the absence of LIF, mES cells with deletions of both alleles of the LIF 
receptor gene (Lifr-/-) were utilised. These cells, called LRK1 cells, can be 
maintained in the absence of LIF by activation of gp130 using interleukin-6 and 
soluble interleukin-6 receptor (IL6/sIL6R). LRK1 cells also encode the Polyoma 
large T protein and were transfected, as described in Chapter 2, with vectors 
containing a Polyoma origin of replication and expressing either rat Nanog (Figure 
3.4C) or mouse Nanog. The empty vector (MT) pCAG-IP (Figure 3.4B) was used as 
a negative control. All vectors contain a puromycin resistance gene. Cells were 
cultured for 14 days in medium containing puromycin and the resultant colonies 
(Figure 3.5A) were stained for alkaline phosphatase and scored as undifferentiated or 
differentiated (Figure 3.5B).  
 As expected, only those cells transfected with Nanog-expressing vectors 
could maintain ES cell self-renewal independent of gp130 stimulation. The MT 
vector control failed to produce undifferentiated colonies in the absence of gp130 
stimulation (Figure 3.5C) and generated only flattened differentiated cells.  
 Interestingly, in the presence of cytokine, there were fewer colonies obtained 
with either Nanog expression vectors compared to the MT vector control. The 
presence of a transgene within the expression vector may interfere with the 
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transcription of the puromycin gene and thus fewer cells produce a sufficient amount 
of puromycin acetyltransferase to survive selection compared with the MT vector. 
 Nonetheless, both mouse and rat Nanog expression vectors maintained 
undifferentiated colonies in the absence of IL6/sIL6R. In both cases the number of 
undifferentiated colonies was fewer in the absence of cytokine than in its presence, 
probably because fewer cells expressed the required level of Nanog capable of 
maintaining self-renewal independent of gp130 stimulation. The colonies formed in 
the presence of cytokine were more compact and rounded compared to the flatter 
morphology observed in the absence of cytokine (Figure 3.5A) as previously 
observed (Chambers et al., 2003). Although the rat Nanog transcript generated fewer 
undifferentiated colonies than the mouse transcript, the relative percentage of 
undifferentiated colonies generated was comparable (Figure 3.5C). Furthermore, 
although less effective than mouse Nanog, rat Nanog was also capable of directing 
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3.5  Discussion 
 Rat ExS cells and other rat ES-like lines fail to maintain significant levels of 
the key ES cell transcription factor Oct4. Oct4 is critical for specification of the 
pluripotent compartment in vivo as well as maintenance of ES cell pluripotency in 
vitro (Nichols et al., 1998; Niwa et al., 2000). The pattern of Oct4 expression in vivo 
is similar between rat and mouse. However, upon isolation and in vitro culture of the 
rat ICM, expression of Oct4 is quickly downregulated (Buehr et al., 2003). 
 However, little is known about the expression pattern of Nanog in rat ExS 
cells or the rat embryo compared with mouse. This is of interest because a common 
spatial expression pattern would suggest that Nanog plays a similar role in both 
mouse and rat, whilst a difference in the temporal expression pattern may highlight a 
more appropriate embryonic stage suitable for successful derivation. It was 
demonstrated that ExS cells do not express Nanog (Figure 3.1A). Also, the temporal 
and spatial expression pattern of Nanog in the rat embryo was shown to be restricted 
to the pluripotent compartments of the early embryo, namely, the inner cells of the 
morula and the ICM of the blastocyst, but excluded from the trophectoderm (Figure 
3.2B). Expression was absent in the E10.5dpc embryo, but re-expressed in E13.5 
gonads (Figure 3.2A). This indicates that rat Nanog is expressed in a similar pattern 
to mouse (Chambers et al., 2003). Furthermore, overexpression of rat Nanog in 
mouse ES cells is capable of mediating gp130-independent self-renewal (Figure 3.5), 
demonstrating a common function with its mouse orthologue and suggesting that it is 
likely to play a similar role. 
 Interestingly, although overexpressing rat Nanog in mouse LRK1 cells 
facilitated gp130-independent self-renewal, the efficiency was less compared with 
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the mouse equivalent (Figure 3.5D). This may simply be due to a difference in 
transfection efficiency or the level of transgene expression. However both the mouse 
and rat transgenes are contained within the same vector and driven by the same 
promoter, it is therefore unlikely that expression of either would differ significantly. 
The difference is more likely due to a variation in transfection efficiency. Only one 
transfection experiment was performed. Therefore performing replicates would 
provide more reliable data. Another consideration is that the ability of rat Nanog to 
function in mouse cells may be impaired. For example, the ability of human NANOG 
to mediate gp130-independent self-renewal in this system is reported to be 
considerably lower than for mouse (Chambers et al., 2003). Although the rat is more 
closely related to the mouse than the human, key differences in the functional 
domains may significantly affect cross-species functionality.  
 The Nanog protein can be roughly divided into 3 domains; the N-terminal 
domain, the homeodomain (HD) and the C-terminal domain. The C-terminal domain 
is further subdivided into the tryptophan repeat (WR) region which is flanked by 5’ 
and 3’ C-terminal sequence, CD1 and CD2 respectively (Pan and Pei, 2005) (Figure 
3.6A). The overall homology between rat and mouse is 83%, compared with 58% 
with human. The highest homology exists within the DNA-binding HD (93%). This 
region is highly conserved and also contains a nuclear localization signal (NLS). A 
region of only six amino acids (aa) has been identified in the human NANOG HD 
and demonstrated to be responsible for exclusive nuclear localization (Chang et al., 
2009). These six aa are conserved between mouse, human and rat (Figure 3.6B).  
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Figure 3.6 Nanog protein domains 
(A) Summary of rat Nanog protein domains: Blue box (N), the N-terminal domain; 
red box (HD), homeodomain; black boxes (C1 & C2), C-terminal domain and yellow 
box (WR), tryptophan repeat region. 
(B) Alignment of rat (Rn) protein sequence with mouse (Mm) and human (Hs) 
orthologues. The alignment was generated using Clustal W: orange, identical in all 
sequences; green, identical in two sequences. The domains are underlined: blue, N-
terminal domain; red, homeodomain; black, C-terminal domain and yellow, 
tryptophan repeat region. The red astrisks represent the putative, conserved nuclear 
localisation signal. The yellow asterisk indicates the additional tryptophan insertion 
in the rat sequence. 
N HD C1 WR C2 
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This suggests that the HD is likely to be functional between species. Another key 
region, which is responsible for Nanog homodimerisation and its ability to direct 
LIF-independent self-renewal, is the WR region (Mullin et al., 2008; Wang et al., 
2008). The lower degree of homology (76%) in this region is mainly due to the 
presence of an extra pentapeptide tryptophan repeat found in rat (Figure 3.6B). It is 
possible that both rat homodimers and rat/mouse heterodimers may form and in both 
cases the binding sites for Nanog targets may differ slightly from pure mouse 
homodimers, thus affecting binding and downstream activity. 
 
3.6 Summary 
 The expression pattern of Nanog in rat ExS cells and the early rat embryo 
was investigated. Although rat ExS cells fail to express Nanog, the expression 
pattern in the embryo is comparable with that of mouse. Expression is restricted to 
the inner compartment of the compacted morula and ICM of the blastocyst and is 
downregulated by E10.5, but upregulated in E13.5 gonads. Furthermore, the rat 
Nanog transcript was isolated and cloned into an expression vector and demonstrated 
to facilitate LIF-independent self-renewal, a defining feature of Nanog 
overexpression (Chambers et al., 2003). Therefore, although both Oct4 and Nanog 
are expressed in the ICM of the rat blastocyst, unlike their mouse orthologues, they 
are both down-regulated in vitro during derivation. This suggests that differences 
exist either in the intrinsic properties of the rat and mouse ICM cells or in their 
response to unrefined extrinsic culture conditions. 
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Chapter 4 
Reprogramming of rat ExS cells 
 
4.1 Introduction 
 The ICM of both rat and mouse blastocysts express Oct4 and Nanog. 
However, during ex vivo culture, rat ICM cells fail to maintain expression of these 
key ES cell transcription factors.  
 In the absence of Oct4 or Nanog mouse ES cells become committed to 
differentiate and pluripotency is compromised (Chambers et al., 2003; Mitsui et al., 
2003; Nichols et al., 1998; Niwa et al., 2000). Conversely, overexpression of Nanog 
is capable of maintaining Oct4 expression and LIF-independent self-renewal of 
mouse ES cells (Chambers et al., 2003). However, Nanog’s ability to maintain LIF-
independent self-renewal requires the continued presence of Oct4 suggesting that 
Nanog and Oct4 appear to act in concert (Chambers et al., 2003). Therefore, it was 
hypothesized that exogenous expression of Oct4 and/or Nanog from integrated 
expression vectors may facilitate reprogramming of ExS cells into an ES cell, 
pluripotent state. 
 The ability to reprogramme the nuclei of differentiated cells into a pluripotent 
state has been demonstrated previously by others using somatic cell nuclear transfer 
(SCNT) and cell fusion technologies. When enucleated Xenopus eggs were 
transplanted with the nucleus from keratinized skin cells of Xenopus they could 
support complex differentiation and development to the tadpole stage (Gurdon et al., 
1975). Later it was demonstrated that the nuclei of adult sheep mammary gland cells 
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could be reprogrammed in a similar manner following nuclear transfer into 
enucleated sheep oocytes (Wilmut et al., 1997). This technology has also been 
applied successfully to rat fetal fibroblasts (Zhou et al., 2003). Establishing gene 
targeting technologies in rat fibroblasts or ExS cells would, when combined with 
SCNT technology, facilitate the generation of genetically modified rats. Animals that 
are born from SCNT exhibit 100% contribution from donor cell DNA. However, 
although this is an advantage over traditional ES cell based chimaera production, 
SCNT is labour-intensive and inefficient. Of 277 reconstructed sheep embryos only 
29 developed to the blastocyst stage, from which one live birth was generated 
(Wilmut et al., 1997). 
 Successful reprogramming of central nervous system cells and bone marrow 
cells has also been demonstrated following spontaneous fusion with mouse ES cells 
(Terada et al., 2002; Ying et al., 2002; Zhou et al., 2003). Although, these hybrid 
cells resemble ES cells morphologically and demonstrate pluripotency, they are 
tetraploid, consisting of DNA from both the ES cell and the differentiated cell, and 
thus cannot contribute to the germline. 
 Collectively, these results demonstrate that the genome of differentiated cells 
has not undergone irreversible modifications, but rather, is amenable to 
reprogramming when exposed to the appropriate factors, such as those found within 
the cytoplasm of the oocyte or expressed by ES cells. 
 Therefore, the aim of the work described in this Chapter was to establish 
DNA transfection protocols for generating stable rat ExS cell transfectants. These 
methods were subsequently utilized for integrating Oct4 and Nanog expression 
vectors into ExS cells. Transgene expression was verified and the capacity of 
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exogenous Oct4 and Nanog expression to induce expression of endogenous ES cell 
markers and reinstate an ES cell identity was investigated.  
 
4.2 Oct4 and Nanog expression vectors 
 The rat Oct4 cDNA, like the rat Nanog cDNA, was amplified from rat E4.5 
embryos by PCR, using oligonucleotides designed to the predicted rat Oct4 mRNA 
sequence XM_228354. Likewise, the restriction enzyme sites XhoI and NotI were 
incorporated into the 5’ ends of the sequences to facilitate subsequent molecular 
cloning, and the Kozak concensus sequence was also inserted into the 5’ end of the 
sequence of one oligonucleotide. The amplified cDNA was cloned into the TOPO 











However, robust sequence integrity was never observed, with the best clone obtained 
containing an ‘A’ to ‘T’ mutation at position 130 and a ‘T’ deletion at position 1011 
(Figure 4.2). 
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As an alternative, mouse expression vectors were considered. The homology 
between rat and mouse Oct4 is 94% and for Nanog it is 87% (94% in the 
homeodomain). Therefore, it was likely that the mouse homologues would be 
functional in rat cells. As such, the mouse Oct4 (Niwa et al., 2002) and mouse Nanog 
(Chambers et al., 2003) expression vectors were utilised (Figure 4.3 B & D). These 
are episomal vectors that carry the Polyoma origin of replication (Py), allowing 
persistent extra-chromosomal expression for many generations in ES cells expressing 
the Polyoma large T protein (Gassmann et al., 1995). Co-expression of the 
puromycin-resistance gene (Pac) is facilitated by the presence of an IRES sequence 
(Mountford et al., 1994). 
 
4.3 Transfection of rat ExS cells 
 Before integrating Nanog and Oct4 expression vectors into ExS cells, it first 
had to be determined whether ExS cells were amenable to transfection and 
generation of stable-expressing transgenic lines, and a suitable transfection protocol 
established.  
 
4.3.1 Trypsinising rat ExS cells 
 Rat ExS cells grow on feeder cells as tightly packed colonies. The colonies 
are surrounded by a sheath-like coating and individual cells within the colony are not 
well defined. Colonies are typically expanded by trituration using a drawn-out glass 
Pasteur. This is a laborious method yielding only several small clumps of cells. This 
is not ideal for transfection, which typically requires a large number of cells 
(approximately 105) in a suspension or grown as a monolayer. Therefore, ExS cell  






















colonies were treated with trypsin. After attempting to disperse the colonies by 
pipetting, it was clear that the colonies were somewhat resistant to trypsin treatment. 
Colonies were then treated with a 4x concentrated stock of trypsin. This allowed the 
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colonies to be dispersed to a near-single cell suspension. When plated at various 
dilutions, large numbers of colonies began to appear after 3-4 days with no overt 
death or differentiation, although plating the cells too densely appeared to have an 
adverse effect on colony growth (Figure 4.4). This may be due to depletion of 
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4.3.2 Lipofection 
 A vector expressing the green fluorescent protein from the jellyfish Aequoria 
victoria (Prasher et al., 1992), which had been altered to produce an enhanced 
fluorescence (Cormack et al., 1996), was employed as a reporter to determine the 
feasibility of transfecting rat ExS cells (Figure 4.5A). The ScaI-linearised 
pPyCAGegfpIP expression vector was transfected into ExS cells by lipofection as 
detailed in Chapter 2. Stable GFP-expressing cells were established and maintained 
in culture for over 20 passages (Figure 4.5B). Since several GFP positive colonies 
were pooled at each passage, and because trypsin treatment of ExS cells does not 
produce a purely single cell population, a Southern blot analysis was performed on 
restriction enzyme digested genomic DNA using a 783bp XhoI EGFP DNA 
restriction fragment probe to determine if the line was a homogeneous population or 
had multiple transgene copies integrated into the genome (Figure 4.6A & B). Two 
restriction fragments are detected in the BamHI and XbaI samples. This data is 
consistent with there being either a single population containing more than one 
integrant or a double population each with a single integration. The larger than 
expected, 5kb XbaI fragment suggests that at least one of the XbaI sites and some 
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4.3.3 Transfection of ExS cells with Oct4 or Nanog 
 A rat ExS cell line was transfected with ScaI linearised pPyCAG-mOct4-IP 
(Figure 4.3B), Floxed-mNanog-IP (Figure 4.3D) and pPyCAG-rNanog-IP (Figure 
4.3C) expression vectors as detailed in Chapter 2. The pPyCAG-IP empty vector 
(MT) was used as a control (Figures 4.3A). Cell lines stably expressing the integrated 
transgene were selected with puromycin. These lines grew in a similar manner to the 
parental line. The morphology was also similar, with the exception of the mNanog 
line which had a more lobular appearance compared to the typical round, ball-like 
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4.3.4 Transgene expression 
 Transgene expression was confirmed in these lines by RT-PCR analysis 
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from rat Nanog and rat Oct4 pCRII TOPO clones (Figure 3.4A & 4.1). Protein levels 
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4.3.5 Characterisation of transgenic rat ExS cells 
 Transgenic lines were maintained at least 30 days post-transfection prior to 
RT-PCR determination of ES cell marker expression (Figure 4.10). No reawakening 
of endogenous Oct4 or Nanog was observed (Figures 4.8A & B and Figure 4.9C). 
Likewise there was no significant up-regulation of the other ES cell markers Fgf4, 
Stella, Rex1 or Sox2. Furthermore, expression of the trophectoderm marker Cdx2 













4.4 Generation of double transgenic rat ExS cells 
Transgenic expression of Oct4 or Nanog in rat ExS cells failed to reawaken 
endogenous ES cell markers. Loss of either Oct4 or Nanog expression causes loss of 
pluripotency in mouse ES cells. Therefore, introduction of either transgene on its 
own is unlikely to be sufficient to induce transformation. It was also observed that 
 - 98 -
ExS cells fail to express the Sox2 (Sry-related HMG-box) transcription factor (Figure 
4.10). 
 Sox2-null embryos die soon after implantation. Although they form a normal 
blastocyst, by E6.0 the embryo structure becomes disorganized, consisting mainly of 
extraembryonic cell types, such as trophoblast giant cells. Outgrowths from null 
blastocysts or isolated ICMs fail to produce ES cells and give rise mainly to 
trophoblast and primitive endoderm. Indeed, RNAi knockdown of Sox2 resulted in 
ES cell differentiation, reduced AP staining and decreased Oct4 levels, but 
upregulation of trophectoderm markers. It has also been demonstrated that the 
enhancer regions of several ES cell-expressed genes contain both Sox2 and Oct4 
binding motifs in close proximity to each other. These studies indicate the synergistic 
activity of Sox2 and Oct4 in regulating genes highly expressed in ES cells, such as 
Fgf4, Utf1 and Nanog , as well as self-regulation (Tomioka, Nishimoto et al., 2002; 
Chew, Loh et al., 2005; Okumura-Nakanishi, Saito et al., 2005). Therefore, Sox2 
plays an important role in maintaining ES cell pluripotency. 
 For these reasons, the mOct4 ExS transgenic line was transfected with either 
a mNanog or mSox2 expression vector to create double transgenic lines.  
 
4.4.1 Zeocin selectable Sox2 and Nanog expression vectors 
 In order to select for cells carrying these second transgenes, a different 
antibiotic selectable marker had to be employed. Therefore, vectors were obtained 
that express mouse Nanog (gift from Jose Silva) or mouse Sox2 and also express the 
zeocin selection marker (Figure 4.11B & C). 
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4.4.2 Generating Zeocin-resistant DIA-M feeder cells 
 To allow selection of cells with zeocin in feeder-dependent culture, a zeocin-
resistant DIA-M feeder layer was established. Neomycin/puromycin-resistant DIA-
M feeder cells were transfected with a ScaI-linearised zeocin-selectable vector 
(Figure 4.11A) as detailed in Chapter 2. Transfected cells were plated at clonal 
density and selected in 20g/ml zeocin. Individual clones were expanded and frozen. 
These were used in the usual manner for culturing ExS cells. 
 
4.4.3 Plating ExS cells on gelatin and laminin 
 The ability of ExS cells to grow in feeder-free conditions was also 
investigated. If the requirement for the DIA-M feeder layer could be removed then 
this would also allow selection in zeocin. Therefore, rat ExS cells were removed 
from feeders by mouth pipetting, trypsinised then plated onto gelatin or laminin-
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 Cells attached readily to laminin-coated dishes, but only poorly on gelatin. 
This made passaging on gelatin very inefficient. In both cases colonies appeared to 
flatten, resembling mES cells, although a population of compacted ball-like colonies 
remained. These did not represent a heterogenous population since passaging 
individual colonies still resulted in both colony types forming. Rat ExS cells could be 
maintained on laminin for at least twenty passages by trypsin dissociation every three 
days and returned to DIA-Ms without any morphological change. 
 
4.4.4 Transfection of mOct4 rat ExS line 
 The mOct4 rat ExS cell line was maintained on laminin-coated plates prior 
and subsequent to lipofection. The cells were lipofected, as detailed in Chapter 2, 
with ScaI-linearised, zeocin-resistant mNanog-IZ or mSox2-IZ expression vectors 
carrying the zeocin resistance gene (Figure 4.11B & C). The pPyCAGIZ empty (MT) 
vector was used as a control (Figure 4.11A). Cell lines stably-expressing the 
integrated transgene were selected in 20g/ml zeocin. These lines grew in a similar 
manner to the parental line and the mOct4 line. In general the morphology was also 
similar (Figure 4.13). 
 
4.4.5 Transgene expression 
 Expression of the Nanog-IZ and Sox2-IZ transgenes was confirmed in these 




















4.4.6 Characterisation of double transgenic rat ExS cells  
 Double transgenic lines were maintained at least 30 days post-transfection. 
RT-PCR analysis was then performed to determine reactivation of ES cell markers 
(Figure 4.14c). Once again, there was no upregulation of endogenous Nanog, Sox2, 
FGF4 or Stella. Interestingly, Rex1 appeared to be up-regulated in the double 
transgenic lines, including the MT vector control (lanes 6, 7 & 8). This is likely due 
to plating on laminin rather than a direct effect of the transgenes. Furthermore, the 
endoderm marker GATA6 and the trophectoderm marker Cdx2 continued to be 
expressed. 
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4.5 Discussion 
 Rat ExS cells stably expressing Oct4, either independently or in combination 
with Sox2 or Nanog, failed to upregulate the endogenous ES cell markers Nanog, 
Fgf4 or Stella. Rather, they continued to express GATA6 and Cdx2, suggesting that 
they have retained their extraembryonic state. Although the function of the 
expression vectors employed had been tested previously by others or as part of this 
project, their function in ExS cells has not been confirmed. Use of luciferase 
reporters containing the relevant enhancer binding motifs would confirm their 
activity. 
 Since the outset of this project several groups have demonstrated 
reprogramming of differentiated cells into pluripotent stem cells using defined 
factors. These have been termed induced pluripotent stem (iPS) cells (Takahashi and 
Yamanaka, 2006). Twenty four factors were initially screened, using retroviral 
transduction, to investigate their ability to induce pluripotency in mouse embryonic 
fibroblasts. The factors were screened collectively and in pools, after withdrawal of 
individual factors. This study demonstrated that co-transduction of only four factors, 
Oct4, Sox2, c-Myc and Klf4, was sufficient to induce complete reprogramming. 
These iPS cells exhibit characteristics of mouse ES cells, such as expression of ES 
markers, differentiation into the three germ layers and contribution to adult 
chimaeras and the germline. Induction of pluripotency has now been demonstrated in 
several cell types and species, including terminally differentiated lines, as well as rat 
fibroblasts (Li et al., 2009) and human somatic cells. Successful reprogramming of 
differentiated cells has also been achieved using vector-based, CAG-driven 
expression, supporting the approach used in this project (Kaji et al., 2009). However, 
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the experiment by Kaji et al employed Nucleofection as a delivery system, whilst 
transfection of ExS cells utilized Lipofectamine, which is known to be less efficient. 
Furthermore, the efficiency may be hindered further due to the difficulty in 
generating a truly single cell suspension of ExS cells prior to transfection.  
 The efficiency of generating iPS cells is typically only 0.001% to 0.03%. 
However, efficiency varies depending on the delivery system employed, the number 
of factors transduced, the cell type transduced and the addition of chemical 
modifiers. It is also clear that the combination of factors used is important. In the 
original experiments, no iPS cells could be generated with only 2 factors. Even, with 
three factors, in the absence of c-Myc, the efficiency was very low and the 
reprogramming rate slower (Nakagawa et al., 2008). Successful reprogramming was 
eventually demonstrated with two factors or with Oct4 alone. However, these iPS 
cells were generated from neural stem cells (NSCs) rather than fibroblasts. NSCs 
express significant endogenous levels of Sox2, Klf4 and c-Myc compared to 
fibroblasts. This suggests that high levels of expression are likely to be an important 
driving force in initiating reprogramming. Interestingly, ExS cells express both c-
Myc and Klf4 (Figure 4.14d), suggesting that in the presence of exogenous Oct4 and 
Sox2 expression, reprogramming could be possible. It would be interesting to 
determine the level of c-Myc and Klf4 expressed in ExS cells relative to NSCs. 
However, NSCs may possess a transcription factor profile or epigenetic state closely 
resembling that of ES cells that facilitates reprogramming in the absence of other 
exogenous factors. 
 It is surprising that Nanog is not one of the core factors required to generate 
iPS cells. Recently, however, it has been demonstrated that Nanog is necessary to 
 - 106 -
promote the formation of the pluripotent state following reprogramming of NSCs 
either by cell fusion with ES cells or by induction with exogenous factors. Although 
Nanog appears to be dispensable for the initial reprogramming process, in the 
complete absence of Nanog cells fail to become fully reprogrammed, but rather exist 
in a dedifferentiated state. This suggests that Nanog is essential for coordinating ES 
cell transcription factors into a functional network that facilitates the transition to the 
fully reprogrammed, pluripotent state (Silva et al., 2009).  
 The aim of this chapter was to generate stable over-expressing lines to 
examine the affect of these transgenes on ExS cells. Therefore, colonies were 
selected based on integration of the transgene rather than on upregulation of an ES 
cell-specific marker, such as Nanog, as a direct result of reprogramming, as used in 
iPS experiments. Nonetheless it is clear that Oct4, whether alone or in combination 
with Sox2 or Nanog, as used in this project, is unlikely to fully reprogramme ExS 
cells. Although high levels of expression could be expected from the CAG promoter, 
other factors are likely to be required either to promote survival or proliferation, or 
initiate chromatin remodeling to establish the correct epigenetic state. Also, the 
transgenes were introduced sequentially, rather than in combination. Any positive 
reprogramming function may be limited due to the absence of other factors whose 
activity may have been required previously or simultaneously. Indeed overexpressing 
any of the four factors in ES cells induces differentiation, senescence or apoptosis. 
Therefore, the balance and relative timing of expression throughout the 
reprogramming event may be important. Unsurprisingly, reprogramming is not 
instant, typically taking around 14 days for colonies to form that have a characteristic 
ES cell morphology and expression profile. 
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4.6 Summary 
CAG-driven Oct4, Nanog and Sox2 expression vectors were intregrated into ExS 
cells to investigate the possibility of transforming these cells into ES cells. Stable 
lines were generated which express either Oct4 alone or in combination with Nanog 
or Sox2. However, no up-regulation of endogenous Oct4 and Nanog, or the other ES 
cell markers, Fgf4 and Stella, was observed. Rather, Cdx2 and GATA6 expression 
were preserved, suggesting that the cells have retained their extra-embryonic identity 
and overexpression of Oct4, Nanog or Sox2 is insufficient to downregulate 
expression of Cdx2 and GATA6. The recent studies generating iPS cells suggest that 
whilst Oct4 and Sox2 are necessary for reprogramming of somatic cells, they are not 
sufficient. Furthermore, the iPS reprogramming efficiency is relatively low, 
suggesting that the exact level of expression of the individual transgenes relative to 
each other may be important. Since ExS cells express Klf4 and c-Myc, exogenous 
expression of Oct4 and Sox2 may be sufficient for reprogramming should the 
relative levels be appropriate. However, the transfection method employed in this 
chapter may not yield sufficient numbers of transfectants to ensure those with the 
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Chapter 5 
Characterisation of authentic rat embryonic stem cells 
derived in defined conditions 
 
5.1 Introduction 
 Whilst mES cells are routinely cultured in feeder-free conditions, culture in 
the absence of both feeders and serum results in neural differentiation. In the 
presence of LIF, neural differentiation is reduced, but not blocked. However, Ying et 
al demonstrated that chimaera forming, germline competent mES cells could be 
derived and maintained in feeder and serum-free culture conditions in the presence of 
LIF when supplemented with bone morphogenetic protein (BMP4). BMP4 blocks 
neural differentiation by induction of Inhibitor of differentiation (Id) genes. 
 It has been demonstrated that differentiation of mouse ES cells occurs via 
autoinductive stimulation of Erk via Fgf4 signalling. Interestingly, neither LIF nor 
BMP4 inhibit Erk activation suggesting that they may act downstream of Erk. 
Recently, Ying et al have demonstrated that inhibition of FGF/Erk signaling by two 
small molecule inhibitors could sustain mouse ES cell self-renewal without 
requirement for LIF or BMP4. However, cell viability is compromised in such 
conditions where Erk activity is reduced. Robust maintenance could be achieved by 
addition of a selective GSK3α/β inhibitor CHIR99021 (CHIR) (Murray et al., 2004). 
The effect of GSK3 inhibition is not mediated via STAT3 phosphorylation or 
upregulation of c-myc or anti-apoptotic factors. Although mouse ES cells cultured in 
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CHIR alone exhibit non-neural differentiation, in combination with FGFR/Erk 
inhibition, differentiation is blocked and growth enhanced. Indeed, both Fgf4-/- and 
Erk2-/- ES cells could be maintained in CHIR only. This, three inhibitor (3i) culture 
condition supported de novo derivation, clonal expansion and contribution to both 
chimaera formation and germline transmission. This suggests that maintenance of ES 
cell self-renewal does not require activation signals, but rather is the default state that 
can be maintained by elimination of differentiation signals. 
 The aim of the work described in this Chapter was to utilize this serum-free 
3i culture condition to determine if established rat ExS cell cultures could be 
transformed into rat ES cells or if rat ES cell lines could be derived under these 
conditions. 
 
5.2 Culturing rat ExS in 3i medium. 
 Rat ExS cells were passaged equally into four different culture conditions and 
cultured for 6 days, with media changes every second day (Figure 5.1). ExS colonies 
grew well in standard ExS cell culture conditions containing GMEM, serum, LIF and 
Matrigel. However, when cultured in 3i, cells stopped growing, no colonies formed 
and the cells appeared differentiated even in the presence of LIF or Matrigel. This 
indicates that blockade of FGFR signalling, pErk activation and GSK-3 signalling is 
insufficient to transform rat ExS cells in the absence of serum. Furthermore, either 
inhibition of one or more of these pathways prevents ExS cell self-renewal or, some 
factor(s) present in serum are required for ExS cell maintenance. 
 
 


















5.3 Derivation in 3i medium 
 Attempts were also made to derive cell lines in 3i from freshly isolated rat 
ICMs of Fischer and DA E4.5 rat embryos (derivations were carried out by Mia 
Buehr as described in Chapter 2). 
 These lines were maintained in order to assess if they possessed the key 
characteristics of ES cells. The cells were maintained on a DIA-M feeder layer and 
could be passaged by single cell dissociation using trypsin or AccutaseTM. These 
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cultures yielded colonies with a morphological resemblance to mES cells and were 























 - 112 -
5.4 Rat 3i expression profile 
 RT-PCR analysis confirmed that rat 3i cells continued to express Oct4 and 
Nanog beyond the time when these markers are normally extinguished during the 
derivation of ExS cell cultures (Figure 5.3A). Furthermore species-specific Nanog 
oligonucleotides were used to indicate that only the rat transcript, and not mouse, 
could be detected in these cells. This data confirmed that these cells were indeed of 
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 Expression of Oct4 and Nanog was also confirmed at the protein level by 
Western blotting. The Oct4 protein level is similar to mES cell levels (Figure 5.3B). 
However, the level of Nanog in rat 3i cells appears considerably lower than that for 
mES cells. Furthermore, at least two bands are detected in samples expressing mouse 
Nanog, but only one band in the rat 3i cell samples. The antibody used is polyclonal 
and was raised against amino acids 2-16 of mouse Nanog, in which there are two 
amino acid differences with rat Nanog. The differences in intensities observed are 
most likely due to differences in epitope specificity between mouse and rat. 
 Further expression analysis, performed by RT-PCR, demonstrated that rat 3i 
cells expressed similar levels of other markers commonly found in mES cells, such 
as Sox2, Rex1, Eras, Stella, Klf4, Errβ and the Oct4/Sox2 target Fgf4 which, like 
Oct4 and Nanog, is not expressed in ExS cells (Figure 5.4A). c-Myc was also 
expressed, but at a level lower than typically seen in mES cells (discussed in Chapter 
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5.5 Differentiation capacity 
 The differentiation potential of rat 3i cells was assessed by teratoma 
formation and chimaera colonization.  
 
5.5.1 Teratoma formation 
 The pluripotential capacity of rat 3i cells was examined by injecting cells, 
from two independent rat 3i lines (lines B and C, derived from Fischer and DA  rats 
respectively), under the kidney capsule of SCID (Severe Combined Immuno-
deficiency) mice (injections were performed by Renee McLay). The teratomas 
formed (Table 5.1) demonstrated multi-lineage differentiation as determined by 
histological analysis (Figure 5.5) (histological analysis was performed by Ron 
Wilkie). Differentiated cell types and structures, such as striated muscle, keratinized 






















5.5.2 GFP-expressing rat 3i cell line 
 The developmental potential of ES cells is best defined by their capacity to 
colonise host embryos and contribute to all three germ layers of the developing 
embryo. Therefore, to track their distribution in midgestaion embryos following 
blastocyst injection, rat 3i cells were transfected with a pPyCAGegfpIP expression 
vector to generate stable GFP-positive cells. Initial attempts to transfect rat 3i cells 
using standard lipofection reagents, such as Lipofectamine 2000TM, Fugene TM and 
OptifectTM were unsuccessful. It was hypothesized that in serum-free conditions cells 
may be sensitive to the disruptive nature of lipofection. The presence of serum may 
protect against this or enhance the recovery of the cells post-transfection. Therefore, 
transfection was performed in the presence of serum using Lipofectamine LTX TM 
(Invitrogen, 15338-100) - a reagent that is optimized for sensitive cells. The serum 
and reagent were removed 16 hours post-transfection. Puromycin selection (1µg/ml) 
was added 48 hours post-transfection and maintained for at least one week. GFP-
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positive, puromycin-resistant colonies were obtained and pooled (Figure 5.6A). 
Stable GFP-expressing cells were injected into E4.5 d.p.c rat embryos. 
 
5.5.3 Mid-gestation and neonatal GFP Chimaeras  
 The presence of a stable GFP reporter in rat 3i cells circumvents the need to 
use specific strains of embryo for injection. Therefore, cells were injected into both 
Fischer and DA blastocysts (injections were performed by Renee McLay and Jan 
Ure). Injected blastocysts were transferred into pseudo-pregnant recipients and 
embryos harvested at E10.5-14.5 d.p.c. No chimaeras were observed using the 










However, two DA-derived lines (D and DA3) produced a total of six GFP-positive 
mid-gestation chimaeras that demonstrated widespread distribution throughout the 
embryo (Figure 5.6B & C). 
 Line DA3 also generated five postnatal chimaeras, three of which died 
neonatally, whilst two had to be sacrificed due to jaw deformity (Table 5.3). 
















Examination of these also demonstrated contribution in several tissues including, 
skin, liver, heart and lung (Figure 5.6D). GFP expression was also observed in the 
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5.5.4 Adult chimaera formation 
 ES cell contribution to the germ cells is critical for germline transmission and 
generating rat disease models. For this purpose attempts were made to generate adult 
chimaeras that would be bred to demonstrate transmission of the ES cell genome 
through the germline. 
 At the time of the initial injections, vasectomised male rats for generating 
pseudo-pregnant female recipients were unavailable. As an alternative, naturally 
mated recipients were used. In order to identify chimaeras by coat colour, Fischer 
(albino coat colour) blastocysts were injected with DA (agouti coat colour) cells then 
transferred to naturally mated DA recipients. Conversely, DA blastocysts were 
injected with Fischer derived cells and subsequently transferred into Fischer 
recipients (injections were performed by Renee McLay and Jan Ure). 
 Five independent Fischer-derived cell lines failed to produce any chimaeras 
from a total of 241 injected embryos (Table 5.3). However, DA-derived cell line C 
produced two, coat-colour, male chimaeras from a total of sixty-four injected 
embryos (Figure 5.7A). 
 The relatively high coat-colour transmission of the chimaeras generated 
suggested that a 100% coat-colour contribution could not be excluded. A 100% coat-
colour transmission would not be detected within a background of naturally born 
littermates. Therefore, genotyping using microsatellite PCR analysis of tail, ear and 
blood samples was routinely employed. 
 Analysis of microsatellite regions D1Rat122 and D3Rat17 by conventional 
agarose gel (Figure 5.7B) and fluorescent ABI-capillary detection (Figure 5.8) 
confirmed coat-colour chimaerism. However, although both chimaeras had a similar  
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contribution as determined by coat colour, the contribution was significantly 
different when other tissue samples were analysed. Chimaera ‘A’ typically had a 
60:40 (Fischer:DA) ratio for tail, ear and blood, whereas Chimaera ‘B’ was 
approximately 90:10. The degree of chimaerism varied according to the tissue 
assayed, with Chimaera ‘B’ demonstrating 10% chimaerism in tail and blood, but 
100% in ear. This skewed coat colour contribution could be explained by the 
influence of the hooded gene (Yamamura and Markert 1981). Presence of the hooded 
gene within melanoblasts retards their migration from the mid-brain region of the 
developing neural crest. Therefore, in this case, the melanoblasts from the F344 
albino hooded host embryo migrate slowly and become restricted to the head region. 
Whereas, the DA agouti non-hooded-derived ES cells migrate normally and 
preferentially contribute to the posterior of the rat. 
 Once vasectomised males became available injections were repeated in 
pseudo-pregnant recipients. However, no further chimaeras were obtained using 
either DA or Fischer-derived cell lines. 
 Sex determination was performed on the rES cell lines by PCR analysis of 
genomic DNA using oligonucleotides designed to the Sry gene (Figure 5.7C). Sry is 
a sex-determining gene linked to the Y-chromosome that triggers male development 
(Sinclair et al., 1990). Detection by PCR demonstrates the presence of the Y-
chromosome. The results indicate that only Fischer-derived lines F and J are male. 
 Therefore, because the injected cell line (C) was female and the chimaeras 
produced were male, they will not support the development of the gametes and germ-
line transmission is not possible. 
 























5.6 Derivation in 2i 
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 It had previously been demonstrated with mouse ES cells, that both the FGFR 
inhibitor SU5402 and MEK inhibitor PD184352 could be replaced by a more potent 
MEK inhibitor PD0325901 (Ying et al., 2008). Inhibition of FGFR is likely to have 
other downstream effects other than reducing phosphor-Erk levels. This modified 
culture medium, called 2i, suggests that MEK inhibition is the important downstream 
effector of FGF signalling necessary for ES cell maintenance. Therefore, lines were 
derived in 2i from the ICM of Fischer, DA and Sprague Dawley E4.5 rat blastocysts 











5.6 Characterisation of rat 2i cells 
 Rat 2i cells are morphologically similar to rat 3i cells and could be 
maintained in the same way (Figure 5.9A). Immunohistochemical and RT-PCR 
analysis confirmed expression of Oct4 and Nanog (Figure 5.9B & C). 
 The capacity of rat 2i cells to contribute to chimaera formation was tested by 
blastocyst injection (injections were performed by Renee McLay and Jan Ure). Four 
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lines generated six chimaeras from a total of 163 injected blastocysts (Table 5.4). 




















However, germline transmission has not been observed from breeding of these 
chimaeras. In contrast the male line SD2, isolated from the albino Sprague Dawley 
(SD) strain, produced one male chimaera, following injection into Dark Agouti (DA) 
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blastocysts, as determined by coat colour and microsatellite analysis (Figures 5.10A 
& B). Importantly, when this chimaera was crossed with a Fischer (F344) female it 
consistently produced litters with albino offspring (Figure 5.10B). Microsatellite 
analysis confirmed transmission of the ES cell genome to these offspring (Figure 
5.10C). Interestingly, the F344 D2Rat250 microsatellite is undetectable in the 
littermate samples due to preferential amplification of the DA D2Rat250 
microsatellite in F344:DA mixed samples (Figure 5.10D).  
 In summary, these findings demonstrate that rat 2i cells possess the key 
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5.7 Electroporation of rat 2i cells 
 The isolation of authentic rat ES cells now provides a valuable tool for 
introducing genetic modifications into the rat genome and generating rat disease 
models for detailed phenotypical analysis. The conventional method employed for 
introducing gene targeting vectors to generate site-specific alterations by 
homologous recombination is electroporation. In this section I examine the feasibility 
of generating stable GFP-expressing rat 2i cell clones by electroporation. 
 Electroporations were performed as described in Chapter 2 with rat 2i cell 
line DA7 using ScaI linearised pPyCAGegfpIP expression vector. The transfection 
rate of human ES cells was improved when a protein-rich medium was used (Zwaka 
and Thomson, 2003). Furthermore, the addition of serum improves recovery of rat 
3i/2i cells following freezing and lipofection (personal observations). Experiments 
were therefore performed to determine the effect of N2B27 and serum in the cell 
suspension medium as well as the effect of increasing DNA concentration. 
Surprisingly, in all cases there was no significant cell death 24 hours post-
electroporation. GFP-positive, puromycin-resistant colonies were counted nine days 
post-transfection. The inclusion of N2B27 and FCS during the electroporation 
reaction increased the efficiency by around 40% over PBS (Figures 5.11A & B). 
There was also an obvious increase in efficiency with increasing concentrations of 
DNA, such that 50µg produced a stable transfection efficiency of 0.052% (Figure 
5.11B). This is higher than that previously reported for human and monkey ES cells 
(Furuya, Yasuchika et al. 2003; Zwaka and Thomson 2003) and similar to that 
typically achieved in mouse ES cells. 
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 Individual colonies were picked, treated with AccutaseTM and plated into 
DIA-M-coated wells of a 96-well plate (Figure 5.11C). The presence of the transgene 
was confirmed for two clones by genomic PCR (Figure 5.11D). Expanded clones 
could be cryopreserved and successfully recovered without loss of GFP expression 
(Figure 5.11E). 
 A notable concern of rat 2i cell culture is the tendency for colonies to detach 
from the feeder layer. This poses a significant practical problem when attempting to 
isolate individual clones. On this occasion individual colonies were removed by 
mouth pipette. Whilst this method is acceptable for small numbers of clones, 
improving cell attachment would allow colonies to be picked by hand pipette 
facilitating medium-throughput experiments. 
 
5.8 Discussion 
 Since their derivation almost 30 years ago, it has become clear that the 
culture conditions established for mouse ES cells cannot be applied successfully to 
all species, or indeed, all mouse strains. The fact that other strains of mice are 
recalcitrant to the same culture conditions suggests that permissive mouse strains 
may be less susceptible to the differentiation cues that exist in such complex 
formulations. 
 Recently, the application of small molecule inhibitors of MEK and GSK3 
was successful in establishing ES cells from both permissive and non-permissive 
strains of mice in defined serum- and feeder-free culture conditions (3i/2i). This 
suggested that inhibition of autoinductive differentiation signals is the limiting factor 
in capturing the pluripotent preimplantation epiblast cell state in vitro, and may be 
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the common requirement that will facilitate derivation from other species. In this 
chapter the application of 3i and 2i defined culture conditions to rat ES cell 
derivation was examined. 
 Utilising these defined culture conditions, rat cells that possessed the typical 
characteristics of ES cells could be isolated from the ICM of Fischer, DA and 
Sprague Dawley (SD) E4.5 embryos. These cells exhibit extensive self-renewal in 
vitro whilst maintaining expression of Oct4 and Nanog and retaining the capacity to 
differentiate into all three germ layers. Most importantly they could contribute to 
adult chimaeras and their genome was transmitted through the germline, 
demonstrating, for the first time, the isolation and expansion of authentic pluripotent, 
germline competent rat ES cells. 
 Their ability to generate chimaeras distinguishes rat ES cells from EpiSC 
(Brons et al., 2007). In addition, unlike EpiSC, rat ES cells express Klf4, Rex1 and 
Stella and can be routinely passaged by single cell dissociation. 
 Interestingly, the level of c-Myc transcript is lower for rat ES cells cultured in 
3i medium compared with mouse ES cells in serum plus LIF. This was also observed 
for mouse ES cells cultured in 3i (Ying et al., 2008). Regulation of c-Myc occurs at 
both the transcriptional and post-translational level. It has been demonstrated that 
transcriptional regulation of c-Myc by STAT3 and suppression of GSK3-mediated 
T58 phosphorylation and subsequent degradation of c-Myc may play a role in mouse 
ES cell self-renewal (Cartwright et al., 2005). Erk is also involved in transcriptional 
upregulation of c-Myc as well as its post-translational stabilisation via S62 
phosphorylation. The low level of c-Myc observed in 3i cultures is likely to be a 
consequence of phospho-Erk suppression. This suggests that high levels of c-Myc 
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are not essential for ES cell self-renewal in this defined, serum-free culture. 
However, CHIR99021 may compensate for the negative effects of Erk, by inhibiting 
GSK3-mediated degradation of c-Myc, thereby maintaining an appropriate level that 
may be necessary for maintenance of self-renewal. 
 Continued blockade of multiple signaling pathways may place unwanted 
selection pressures upon the cells. Whilst it is clear that blockade of Erk inhibits 
differentiation and facilitates self-renewal it is unclear what, if any, side effects this 
may have on the cell. The FGFR inhibitor SU5402 and the weaker MEK inhibitor 
PD184352 could be replaced with the more potent MEK inhibitor PD0325901. This 
not only simplifies the culture conditions, but also removes potentially undesirable 
consequences of FGFR inhibition, such as PI3K blockade. Whilst the capacity for 
prolonged self-renewal and maintenance of pluripotency are important 
characteristics, maintaining genomic integrity is essential for ensuring germline 
transmission (Liu et al., 1997). The capacity for germline transmission has been 
demonstrated for the rat ES cells isolated here, establishing their value as a research 
tool. 
 However, the jaw deformity observed in chimaeras from 2 independent lines, 
of which one demonstrated a trisomy for chromosome 9 (Buehr et al., 2008), raises 
concerns over the quality of some lines and the robustness of the culture system. 
Furthermore, there was also a female sex bias observed in the initial lines derived in 
3i (Figure 5.7C). It is unclear whether all of these are genuine female lines or if some 
represent male lines which have lost their Y chromosome. Concern over germline 
potency, is also raised by Li et al. They have observed an increase in chromosomal 
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abnormalities with higher passages. Karyotypic analysis of the cells would confirm 
this.  
 Examination of birth rates and chimaera rates highlights other concerns 
(Table 5.5). Only 16-18% of transferred embryos produce liveborn pups. Such low 
efficiency would only be cost effective should the rate of chimaerism be high. This is 
not the case here where only 12-16% of the pups born are chimaeras. The work co-
published by an independent laboratory, report a similar birth rate (Li et al., 2008). 
However, in contrast, 77% of their pups were chimaeric. Such differences may be 
explained by the quality of the cells injected. If the cells are in some way sensitive to 
these conditions then quality control of culture medium and routine cell maintenance 
is critical. Routine enzymatic dissociation may also be detrimental to the health of 
the cells. 
 Long-term propagation of rat ES cells in the absence of feeders has yet to be 
demonstrated. This suggests that cell attachment and/or factors generated by feeder 
cells may be necessary for additional support. Therefore, the type and density of the 
feeder layer used may contribute to the quality of the ES cells which they support. In 
the work described here, mouse 10T1/2 fibroblasts expressing matrix-bound LIF 
were used at a density of 0.75x104/cm2 whereas Li et al used primary mouse 
embryonic fibroblasts at 5x104/cm2. The quality of the embryos used for injection 
may also contribute to the integration of the donor cells. 
  Li et al demonstrated germline transmission using a donor cell:host embryo 
combination of DA:Fischer. Interestingly, germline transmission was not observed 
when the same cell line was injected into SD embryos, despite an equivalent 
 


















percentage of chimaeras being born. This suggests that specific combinations of 
donor cell and host embryo may be important for efficient germline transmission. 
However, the combination demonstrating germline transmission here was SD cells 
into a DA embryo suggesting that more than one combination is suitable. 
Collectively, this data demonstrates germline transmission of rat ES cells from both 
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Table 5.5 Comparison of birth and chimaera rates. 
These tables compare the birth rate and chimaera rate between 
3i and 2i cells and also between the work performed in this project 
with that of Li et al, 2008. Comparisons were made only between 
transfers from DA cell lines injected into Fischer blastocysts. 
 
a Six litters were born from transfers into naturally-mated recipients. 
This figure was adjusted to include only pups born from transferred 
blastocysts (albino or chimaeric), but not those from the natural 
mating (agouti). The total born was eighty nine.
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 Interestingly, no chimaeras were produced by Fischer cell lines, both in this 
work and in that of Li et al. It is possible that DA host embryos do not support 
efficient integration and development of Fischer-derived cells. However, it is also 
possible that the cells themselves have restricted potential to integrate or differentiate 
in vivo. Although Fischer cells demonstrated teratoma formation, the adult kidney 
provides quite a different environment from that of the early embryo. Injection into 
blastocysts requires the donor cells to respond in the appropriate manner and time 
alongside host cells. Fischer cells may possess subtle intrinsic differences, which 
alone or in combination with the culture conditions have an adverse effect on their 
potential. One possibility is that Fischer ES cells mey be more prone to develop 
aneuploidy in 2i/3i culture conditions compared with cell lines derived from DA. 
Detailed karyotypic analysis between several lines from different strains may 
highlight this. 
 A more specific problem may arise from continued culture in CHIR99021. 
During mitosis the chromosomes align on the metaphase plate of the mitotic spindle 
and the sister chromatids become attached to opposite poles. The sister chromatids 
are then pulled apart to opposite poles during anaphase. This bipolar orientation 
ensures equal segregation of genetic material to the daughter cells. The spindle is 
composed predominately of microtubules. During mitosis microtubules are 
constantly growing and shrinking. Careful control of such dynamics is necessary to 
ensure appropriate spindle formation and successful chromosome segregation during 
cell division (Compton, 2000). It has been demonstrated that GSK3 associates with 
both the centrosomes and microtubules during spindle formation (Wakefield et al., 
2003). Interestingly, spindle-associated GSK3 activity is spatially regulated. Within 
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the centrosome active PKB phosphorylates and inactivates GSK3 whilst 
microtubule-associated GSK3 remains unphosphorylated and active. Inhibition of 
GSK3 using small molecule inhibitors causes spindle defects and chromosome 
misalignment. Microtuble dynamics are restricted resulting in suppressed 
chromosome movement and misalignment. This study was supported by others using 
a panel of GSK3 inhibitors, one of which was CHIR99021 (Tighe et al., 2007). 
Although the cells used in these experiments were predominantly cancer cell lines, 
and the concentration of CHIR99021 used was more than three times that used in this 
project it would be interesting to determine if potent GSK3 inhibition generates 
genomic instability in rat ES cells. 
 Furthermore, the ability to genetically manipulate rat ES cells whilst retaining 
germline potency is essential to be able to create rat transgenics with targeted genetic 
alterations. However, this first requires that suitable transfection protocols are 
established and optimized. In answer to this I have demonstrated that rat ES cells are 
transfectable by both lipofection and electroporation. The requirement for feeder 
cells complicates gene targeting by limiting the range of selection strategies that can 
readily be applied. Feeder cells resistant to the relevant drug-selection(s) would first 
need to be established. Furthermore, contact crossfeeding of toxic metabolites is 
likely to present a problem between the feeder cells and ES cells which differ in their 
resistance. Establishing feeder-free culture will further refine the culture conditions 
and remove technical limitations. 
 Whilst it is clear that further work is required to establish robust culture 
conditions, the isolation of authentic rat ES cells provides, for the first time, the 
necessary platform for precision genetic engineering in the rat, and the prospect of 
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creating knock-out rat models. Establishing efficient differentiation protocols will 
provide the necessary tools for drug discovery and cell replacement therapies. It will 
also be of interest if these defined culture conditions will serve as a universal 
solution for the isolation of ES cells from multiple species. 
 
5.9 Summary 
 A defined serum-free culture condition employing small molecule inhibitors 
of MEK and GSK3 was applied to rat ICM cultures. Lines were established from 
Fischer, DA and Sprague Dawley rat strains that could be passaged extensively in 
vitro whilst maintaining expression of Oct4 and Nanog. The expression of Rex1, 
Stella and Klf4, together with the potential to contribute to chimaeric animals, 
distinguishes these cells from EpiSC. Furthermore, the transmission of the rat 2i cell 
genome through the germline of chimaeric animals fulfils the key criteria of ES cell 
identity. However, there are concerns regarding the genomic integrity of these cells. 
These will only become evident if more cell lines and chimaeras are tested. Further 
refinement and optimisation of both cell and rat embryo culture conditions could be 
required to ensure efficient and cost-effective production rat disease models. 
Nonetheless, this work has, for the first time, succeeded in establishing genuine self-
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Chapter 6 
Concluding Remarks 
 It has been almost 30 years since mouse ES cells were first generated. This 
discovery has, together with the application of sophisticated genome modification 
technologies, greatly facilitated the study of gene function and disease research. 
Despite these benefits, there are occasions where other species would serve as more 
relevant models, better suited to studies of physiology and other areas of biomedical 
research. The rat is one such species. Not only does its larger size facilitate 
experimental analysis and sampling, but it also possesses behavioural and 
physiological advantages which make it the preferred model of choice for basic 
research. A significant number of inbred disease models have been generated in rat 
over the last century which has led to a vast wealth of knowledge that can be applied 
to any new knockout rats. The generation of rat ES cells would therefore facilitate 
equivalent applications to rat genetics and provide another, yet more valuable, tool at 
the disposal of the researcher. 
 However, efforts to derive rat ES cells have demonstrated only limited 
success. As discussed earlier in this thesis, rat ES-like cells previously established in 
this laboratory, self-renew in vitro and resemble mouse ES cells morphologically, yet 
fail to express the key ES cell transcription factor Oct4, or generate chimaeras. The 
homeodomain transcription factor Nanog also plays an important role in ES cell 
pluripotency. Nanog is capable of maintaining LIF-independent self-renewal of 
mouse ES cells in vitro whilst in vivo it is required for the maturation of the ICM 
cells into pluripotent epiblast. 
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 The work described in this thesis further demonstrated that whilst the 
expression pattern of Nanog during early development of the rat embryo was 
comparable to mouse, expression was absent in rat ExS cells. However, similar to its 
mouse orthologue, rat Nanog is also capable of facilitating LIF-independent self-
renewal. These data suggest that Nanog is likely to play a similar role in the rat, and 
that its downregulation during derivation, along with that of Oct4, contributes to loss 
of pluripotency. 
 It was hypothesised that stably integrating Oct4 and Nanog expression into 
the ExS cell genome may facilitate in reprogramming these cells into an ES cell 
pluripotent state. However, despite exogenous expression of Oct4 and Nanog the 
cells failed to express typical ES cell markers or activate endogenous Oct4 or Nanog. 
Rather the cells appeared to retain their extraembryonic character. The key 
trophectoderm transcription factor Cdx2 is highly expressed in rat ExS cells and 
remains so, despite transgenic expression of Oct4 and Nanog or Sox2. 
 It has been demonstrated that repression of Oct4, to below 50% of 
endogenous levels, results in differentiation of mES cells into trophectoderm (TE) 
cells (Niwa, Miyazaki et al. 2000). This differentiation is also observed upon over-
expression of Cdx2, suggesting that a reciprocal inhibition exists between Oct4 and 
Cdx2 (Niwa, Toyooka et al. 2005). Furthermore, in wild type mouse blastocysts Oct4 
and Nanog are confined to the ICM, however in Cdx2-/- blastocysts, both Oct4 and 
Nanog are mis-expressed in the trophectoderm (Strumpf, Mao et al. 2005) suggesting 
that Cdx2 may repress Oct4 and Nanog. 
 Therefore, it was hypothesised that up-regulation of Cdx2 expression during 
rat cell derivation may be responsible for Oct4 and Nanog down-regulation and the 
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failure to establish rat ES cells in the presence of serum plus LIF. Therefore, a 
solution would be to reduce Cdx2 expression by RNA interference-mediated 
knockdown (Meissner and Jaenisch, 2006). However, because Cdx2 expression in 
ExS cells is not significantly altered by transgenic Oct4 and Nanog expression, it 
suggests that the fate of these cells may have become highly restricted early during 
derivation, and thus application of RNAi-mediated knockdown in established cells 
may not be sufficient to transform them into an alternative state. Therefore, Cdx2 
knockdown may be required during the initial stages of the derivation process. One 
alternative would be to intervene during the first few days after plating the ICM, a 
point when Oct4 is still expressed and Cdx2 is likely to be up-regulated. The second 
alternative would be to induce knock-down in freshly isolated morulae, a point when 
Oct4 and Nanog are still expressed and prior to exposure to culture medium.  
 The failure to establish ES cells from a species so closely related to the 
mouse suggests that subtle intrinsic differences may impose sensitivity to complex, 
undefined culture conditions such that the pluripotent state of the ICM fails to be 
captured. 
 This project concluded by characterising ICM-derived rat cells that had been 
derived in a recently established and defined culture medium containing inhibitors of 
MEK and GSK3α/β. This work, for the first time, demonstrated the generation of 
self-renewing, pluripotent rat ES cells capable of germline transmission. The 
establishment of germline competent rat ES cells will allow technologies previously 
optimised in mouse, to be applied to the rat, providing a valuable functional tool to 
the researcher. As a first step toward this goal this project has successfully 
demonstrated stable integration of DNA into these rat ES cells by both lipofection 
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and electroporation. Furthermore, individual colonies could be isolated and expanded 
in a 96-well format and successfully freeze/thawed. This will facilitate attempts to 
generate rat genetic models by homologous recombination, making possible the 
study of gene function by constitutive or conditional gene knock-out. Considerations 
will also need to be given to the efficiency of gene targeting in rat ES cells. In the 
long-term future even more sophisticated genomic engineering strategies may be 
possible such as recombinase-mediated genomic replacement (RMGR) (Wallace, 
Marques-Kranc et al. 2007). This latter technology allows the replacement of large 
segments of DNA, of 100kb or more, at specific loci. This facilitates the replacement 
of a gene and all its regulatory elements in the model organism’s genome with the 
syntenic region of the human genome. This humanisation of the mouse genome 
generates authentic mouse models of human disease and addresses instances where 
mutations in the mouse genome do not mimic that of the human condition. The 
generation of rat ES cells may therefore allow humanisation in a species with a 
greater scope for phenotypic analysis, and a better understood and more relevant 
physiology than mouse. 
 One concern regarding the generation of rat models via ES cells will be the 
time and cost required for breeding to obtain germline transmission and subsequently 
homozygosity of gene targeted mutations. This is also a concern with mouse, 
although, mice become sexually mature at 4-6 weeks, whilst rats take 8-12 weeks. 
Typically injection of ES cells into blastocyst-stage embryos yield chimaeric F0 
animals with only partial contribution from the ES cell line. Assuming the ES cells 
have contributed to the germ cells these chimaeras can be bred to generate 
heterozygous F1 progeny, which when intercrossed can produce F2 homozygotes. 
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This process would therefore take around 6 months from birth of the chimaera to 
birth of the homozygote. A solution to this is to generate F0 rats that are completely 
ES cell-derived rather than chimaeric, thus allowing immediate phenotypic analysis 
without extensive breeding. This relies on the ability to generate developmentally 
compromised tetraploid embryos that can be generated by electrofusion of two 2-cell 
stage diploid embryos (Kubiak and Tarkowski, 1985). When mouse ES cells are 
aggregated with tetraploid embryos, the tetraploid cells fail to contribute to the 
embryo proper, but rather are restricted to the extra-embryonic lineages whilst the ES 
cells develop normally (Nagy et al., 1990). This approach was demonstrated to 
generate fully ES cell-derived F0 mice (Nagy et al., 1993).  Recently, F0 mice fully 
derived from gene targeted ES cells was demonstrated following laser-assisted 
injection of ES cells into 8-cell embryos (Poueymirou, Auerbach et al. 2007). Unlike 
tetraploid complementation, this method yields equivalent numbers of healthy mice 
as traditional blastocyst injection, and thus is better suited to large-scale studies. 
 Efforts to establish these technologies in rat will be facilitated by the 
important resources that have been developed in the last decade, such as the 
sequencing of the rat genome, establishment of the rat genome database and BAC 
clone resources. At the same time, the generation of authentic rat ES cells will 
enhance the importance of such resources and hopefully fuel their continued support 
and development. 
 It is interesting why rat ES cells could not be derived using traditional mouse 
ES cell culture conditions. If 3i/2i medium acts by capturing the pluripotent cells that 
reside within the embryo, then application of this approach may prove successful in 
isolating ES cells from other species. This assumes that the mechanisms for 
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establishment and maintenance of pluripotency are conserved between species and 
that blockade of Erks in other species is sufficient to preserve pluripotency. 
Furthermore, it needs to be determined, for other species, the exact embryonic stage 
at which the pluripotent cells exist. By comparison to rodents, formation of the 
pluripotent cells in larger mammals, for example, may be transient or develop in a 
different manner which may make isolation with 3i/2i difficult. One limiting factor in 
assessing the effectiveness of 3i/2i on the derivation of ES cells from larger 
mammals is the availability of a suitable number of quality embryos. Other factors 
must also be considered regarding the in vitro culture conditions such as O2 and CO2 
concentrations, pH and temperature, which may be required to be optimised  for 
efficient survival and growth of the cells. 
 Nonetheless the generation of rat ES cells provides another valuable tool for 
disease modelling and also presents an opportunity to further investigate the common 
basis of pluripotency. Comparative analyses of rat and mouse ES cells, as wells as 
comparison of ES cell lines derived in LIF or 2i culture conditions, may highlight 
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